Browse by Track

(M0930-01-01) The Impact of Oxidative Modifications on the Bioavailability of Subcutaneously Administered Therapeutic Monoclonal Antibodies

(M0930-01-02) A Low Level, Carryover Free and Wide Range, LC-MS/MS Method for Quantitation of Semaglutide from Human Plasma

(T0930-01-02) Advancing Biomarker Assay Validation: From Supportive Secondary Endpoint to Primary Endpoint for Regulatory Decision Making in Generalized Myasthenia Gravis

(T0930-01-03) Investigating How Ionizable Lipids Impact the Cargo RNA Organization in Lipid Nanoparticles Using Small Angle X-Ray Scattering (SAXS)

(M0930-01-03) The Tale of Two Methods: Understanding the Roles of IEX and icIEF for Monitoring Charge Heterogeneity of Stressed Biotherapeutics

(M0930-01-04) Cell Line–Anchored H-Score Strategy Defining Claudin-6 Expression Patterns in Ovarian Cancer

(M0930-01-05) Novel Light Scattering Solutions for Accelerating Development of Antibody-Drug Conjugates

(T0930-01-05) Targeting SA-85 Trans-Sialidase with VLP-Based Peptides: A Promising Immunologic Strategy Against Chagas Disease

(T0930-01-06) Improved SPR Signal Enhancement in Bioanalytical Assays Using Micropolymer-Conjugated IHC Reagents

(T0930-01-07) Development and Validation of a Colorimetric Assay for Quantification of N-acetyl-β-D-glucosaminidase in Human Urine Using NAG-Based Calibration Standards and Quality Controls

(T1030-01-01) Feasibility of Adding Volumetric Absorptive Microsampling (VAMS®) Using Mitra® Tips to an Established ELISA Assay to Determine Concentrations of a Monoclonal Antibody in Whole Blood

(M1030-01-03) Integrated High-Throughput Platform for Covalent Inhibitor Screening and Characterization

(T1030-01-05) A Validated Hybridization LC-MS/MS Method for Quantitative Bioanalysis of HT-KIT, a Vivo-Morpholino Antisense Oligonucleotide

(M1030-01-05) Enantiomeric and Regioisomeric Separation of Triacylglycerides in Liver Samples from Doxorubicin-Treated Rats Using LC-ESI-MS with Coupled CHIRALPAK IF3 Columns

(M1030-01-06) Comparison of Novel Whole Blood Preservation Methods as Alternatives to Cryopreserved PBMC for Immunophenotyping in Multicenter Clinical Trials

(T1030-01-06) Generic ADA Method Development for Preclinical Study

(T1030-01-07) Development of an Immunoassay to Evaluate Transgene Product Expression from an Investigational Gene Therapy to Treat Dry Age-Related Macular Degeneration (dryAMD) in Various Non-clinical Studies

(M1130-01-01) Development and Validation of a Sensitive LC-MS/MS Method for the Quantification of SGR-1505 in Human Plasma to Support Clinical Pharmacokinetic Studies

(M1130-01-02) Can Microsampling Devices Coupled with Intact Mass High-Resolution Mass Spectrometry Improve M-Protein Monitoring and Simplify Minimal Residual Disease Assessment in Multiple Myeloma?

(M1130-01-03) Custom MSD U-PLEX for the Quantitation of CXCL3, CXCL5, and CXCL10 in Human CSF

(T1130-01-03) Sensitive LC-MS/MS Method for Cationic Ligand-Conjugated siRNA Therapeutics

(M1130-01-04) Evaluating the Impact of Matrix on Ex Vivo Stimulation Flow Cytometry in Bioanalysis

(T1130-01-05) CYFRA21-1 Sensing Gold Nanoparticles Based Diagnostic Kit for Non-Small Cell Lung Cancer

(M1130-01-05) Determination of the Concentration of Recombinant Human Heparan-N-Sulfatase (rhHNS) in Human Serum Using a Ligand Binding Assay (LBA)

(M1130-01-06) Challenges and Solutions in Ion-Pair Reversed-Phase LC–MS/MS Assays for the Quantitation of Novel Oligonucleotides: A Case Study

(M1230-01-01) Determination of One Significant Protein in Human Cerebrospinal Fluid (CSF) by LC-MS/MS

(T1230-01-02) A Validated Assay for LC-MS/MS Analysis of an siRNA Therapeutic Drug Using Microsampling Devices

(M1230-01-03) Optimized PEG-Biotin Functionalized QCM-D Sensor for Rapid Detection of a Sepsis-Associated Biomarker

(T1230-01-04) Method Development and Validation of an Antidrug Antibody Assay for a Novel Bispecific Biotherapeutic – Overcoming Challenges from Pre-Existing Antidrug Antibody and Target Interferences

(M1230-01-05) Rapid and Reproducible TAb/NAb anti-AAV Assays Across Serotypes and Species to Support Global Preclinical Programs

(M1230-01-07) Development, Optimization and Qualification of an IFN-γ ELISPOT Assay for Human PBMCs

(T1330-01-01) Identification of Vendor-Specific Interactions in Antibody HRP Conjugates that Impact Bioanalytical Assay Performance

(M1330-01-01) Quantitation of Total and Free Cortisol in Cynomolgus Monkey Serum Using LC-MS/MS

(M1330-01-02) Biomarker Assay Development and Qualification for Measurement of 5-Methylthioadenosine and Symmetric Dimethylarginine in Human Matrices Using One-Sample Multi-point External Calibration Curve Approach

(T1330-01-04) Pre-Formulation Characterization and Stability Evaluation of a Novel Peptide-Based Drug for Triple-Negative Breast Cancer Treatment

(T1330-01-05) CTLA4 SPLEX Assay Validation and Analysis on Disease and Healthy Donor Sample

(M1330-01-06) Challenges in Developing LC-MS/MS and LC-UV Methods for Modified MicroRNAs: A Case Study of Two RNA Mimics and an Inhibitor with Antiasthmatic Potential

(T1330-01-07) A Novel LC-MS/MS-Based Method for Quantification of Human Serum Properdin: Development, Qualification, and Validation

(M1330-01-07) Critical Insights into Method Qualification for Virus-Like Particle (VLP) Blockade Assays to Human Norovirus

(M1530-01-02) Game of Clones – Investigating the Implications of Mouse Strain and Adjuvant Selection on Sequence Diversity of Monoclonal Anti-ID Reagents

(T1530-01-02) Maximizing Reproducibility and Sensitivity in qPCR for Detecting Transcripts Over a Broad Dynamic Range in Response to Anti-PD-1 Therapy

(T1530-01-03) The Development and the Applications of a Multiple Reaction Monitoring (MRM) Method for Bile Salt Export Pump (BSEP) Measurements in In Vivo and In Vitro Models for Early-Phase Drug Development

(T1530-01-04) Multi-Attribute Quantification of mRNA-Lipid Nanoparticle Therapeutics Using Light Scattering

(M1530-01-04) Resolving Adsorption in Urine Based Kidney Biomarker Assays

(M1530-01-05) Comparative Analysis of Replication-Competent Vector Quantification: Whole Blood vs. PBMCs in Gene Therapy Monitoring

(T1530-01-07) Singlicate Analysis of Anti-Antigen IgA in Human Serum with Ligand-Binding Assay

(T0930-01-01) Evaluation of a Novel Solid Phase Extraction for the Determination of Oligonucleotides from Biological Matrices and Analysis Using UPLC-MS/MS

(M0930-01-06) Comprehensive LC-MS Analytical Assays for Antibody-Oligonucleotide Conjugate (AOC) and siRNA Linker-Payload Characterization

(M0930-01-07) Development and Validation of a Sensitive Method for Quantification of Acalabrutinib and ACP-5862 in Human Plasma Using HPLC‑MS/MS

(M1030-01-01) Comparison of Linker-Payload Cleavage Methods of the Antibody Drug Conjugate Anetumab-MMAE to Determine the Conjugated Payload MMAE Concentration by LC-MS/MS

(T1030-01-02) Evaluation of LC-MS Coupled with a Single Quadrupole Mass Spectrometer for Drug Concentration Analysis in Plasma Samples

(M1030-01-02) Scaled Net Analyte Signal Distance (SND) - A Leverage-Based In-Model Diagnostic for Iterative Optimization Technology (IOT) Algorithm

(T1030-01-03) Significant Species Differences in Buprenorphine Metabolism: A Pharmacokinetic Comparison of Metabolite Exposure

(M1030-01-07) Validation of Anti-Drug Antibody Assay for Multi-Domain Biologics for Human Clinical Studies

(T1130-01-02) Transforming Quantitative Sensitivity for Small Molecule Analysis Using a High-Resolution Workflow

(T1130-01-06) Species and Gender-Related Variations in Dehydroepiandrosterone Sulfate Biliary Excretion: A Comparative LC-MS/MS Analysis

(T1130-01-07) Metabolite Profiling and Identification Strategy for the First-In-Human Study

(T1230-01-01) Development and Validation of a Novel LC-MS/MS Method for the Simultaneous Quantification of Alvocidib and Its Glucuronide: Application to Pharmacokinetic and Tissue Distribution Study in Rats

(M1230-01-02) Bridging Strategy Methods for an Accelerated Late-Stage mAb

(T1230-01-03) Absorption, Distribution, Metabolism, and Excretion of ION775, a Hepatocyte-Targeting siRNA Designed to Silence APOC3 Expression, Evaluated After Single and Multiple SC Dose(s) in Mice and Monkeys

(M1230-01-06) Quantification of Tirzepatide in Rat Blood by a Sensitive and Robust UPLC-MS/MS Method: Development and Validation

(T1330-01-02) MRM Based Free Fatty Acids Profiling in Human Plasma and Serum Using LC-MS/MS

(T1330-01-03) LC/MS/MS Assays for Three Novel Oxazolidinones with Potential Anticonvulsant Effects and Their Application in Pharmacokinetic Studies in Rats

(M1330-01-03) Plasma and Gastrointestinal Tissue Analysis of Prednisolone in Mice Following LPS-Induced Inflammation

(T1330-01-06) Hidden Dangers: The Serious Risk of Adulterated Herbal Supplements to Patient Health

(M1530-01-01) Untargeted Lipidomics Identifies Distinct Metabolic Alterations in Huh-7 Hepatocellular Carcinoma Cells Receiving Monotherapy or Combination Therapy with Atorvastatin and Doxorubicin

(T1530-01-05) Evaluating Açaí Cytochrome P450 Inhibitors Using High-Resolution Mass Spectrometry and Machine Learning Based Biochemometric Analysis

(T1530-01-06) Development of an Ultra-sensitive and Highly Selective Method for Quantification of Monomethyl auristatin E (MMAE) in Human Plasma Using HPLC‑MS/MS

(W0930-03-15) Amorphous Aprepitant Prepared by Spray-Freeze-Drying can be Stabilized with Low Viscosity HPC Grades

(T0930-03-15) Exploring Bacterial Peptidoglycan as a Vaccine Platform

(M0930-03-15) Synergistic Cannabichromene–Cannabidiol Co-Therapy Reprograms Signaling, Epigenetics, and Pharmacokinetics to treat Drug-Resistant Triple-Negative Breast Cancer

(T0930-03-16) Oxaliplatin Inhibits Oncogenic Signaling to Potentiate Radiation Response in Preclinical Models of Radioresistant Glioblastoma and Outperforms the Clinical Standard-of-Care Temozolomide

(M0930-03-16) Paclitaxel Nanomicelles in 2D Monolayer and 3D Multicellular Spheroid Models of Triple-Negative Breast Cancer

(M0930-03-17) Effect of Vasculotropic Dutch Amyloid Beta 40 on Blood-Brain Barrier (BBB) Endothelial Trafficking and Signaling

(W0930-03-17) Enhanced Transdermal Delivery of Tizanidine Using Novel Cavity Hydrogel-Forming Microneedles

(T0930-03-17) Targeted Chemoprevention of Ovarian Cancer Using a Redox-Sensitive PCQ-Gemcitabine Conjugate

(W0930-03-18) Aberrant Splicing of PI3Kδ Promotes Drug Resistance in Hematological Malignancies

(T0930-03-18) Accurate Quantification of DNA Methylation and Hydroxymethylation in Biosamples Using Liquid Chromatography–Tandem Mass Spectrometry

(M0930-03-18) Exofection as a Therapeutic Modality: Restoring P-gp Activity via Trophoblast-Derived Extracellular Vesicles in Neuroinflammatory Disorders

(M0930-03-19) Identifying the Targets of Ocular Tissue-Targeting RNA Aptamers by Proteome Integral Solubility Alteration (PISA) Assay

(T0930-03-19) Mesoporous Silica Nanoparticles-Based Radionuclide Therapy Demonstrates Immunomodulatory Effects and Enhanced Treatment Outcome in Peritoneal Cancer Model

(T0930-03-20) Dissolution Profile Control of Novel Ketoconazole Complexes Using Different Coformers

(W0930-03-20) Formulation of Freeze-Dried Self-Emulsifying Dual Oral Drug Delivery Systems in the Treatment of Breast Cancer

(M0930-03-20) Live Cell NanoLuciferase Assay Based Identification of Ligand Specific Monoclonal Anti-RAGE Antibody

(W0930-03-21) H-89 Exhibits Synergistic Antimicrobial Efficacy With Colistin Against Klebsiella pneumoniae Through Elevated ROS Level

(M0930-03-21) Hot-Melt Extruded Implants Loaded with Brinzolamide for Intravitreal Drug Delivery

(T1030-03-15) Coarse-Grained Molecular Dynamic Simulations of Protein-Membrane System

(M1030-03-15) Metformin Induced-Oxidative Stress Modulates Cellular Redox Homeostasis and Suppresses Cell Growth in Early and Late-Stage Prostate Cancer Cells

(W1030-03-16) Design and Biopharmaceutical Characterisation of Ciprofloxacin Ester Salts: Assessing Solubility and Permeability Dynamics through Molecular Descriptors

(T1030-03-16) Enhancing Transdermal Delivery of Salbutamol via Optimized Nanoemulsion Formulations: The Impact of Surfactant Selection and Component Ratios

(M1030-03-16) Method Development for Antimicrobial Efficacy Test in Anhydrous Based Products

(T1030-03-17) Breaking Barriers: Quinazoline-Scaffolded Kinase Inhibitors with Optimized Blood Brain Barrier Permeability to Treat CNS Malignancies

(M1030-03-17) Development of Monocarboxylate Transporter 4 Inhibitor/Docetaxel-Loaded Smart Layer-By-Layer Nanoparticles for Prostate Cancer Therapy

(W1030-03-17) Fabricating Inhalable PLGA Nanoparticles for Targeted Therapy in Non-small Cell Lung Cancer

(T1030-03-18) In Vivo Tissue Distribution of a Model PROTACs and Its Metabolites Following Subcutaneous Administration To Male Rats Via DESI - MS Imaging

(T1030-03-19) Calcium-Enhanced Chromatography for the Purification of Polar Ammonium and Peptide Compounds

(W1030-03-19) Comparison of Exosome Isolation Methods for the Analysis of a Disease Biomarker in Serum and Urine by PCR Methodologies

(M1030-03-19) In Silico Modeling Helps Predict Antibody Solution Behavior with Charged Cargo Moieties

(W1030-03-20) Assessing the Impact of Varying DMSO Concentrations on Immunogenicity Readouts in Macrophage and Dendritic Cell-Based In Vitro Models

(M1030-03-20) Development and Implementation of a Ferret Venous Catheterization Model for Pharmacokinetic Studies

(T1030-03-20) Therapeutic Potential of Dual-Action Antibody-Drug Conjugates as a Novel Strategy for Cancers Heterogeneously Expressing RON Receptor Tyrosine Kinase

(W1030-03-21) Improved Model Development for Accelerated Colon Polyp Growth in Pirc Rats

(M1030-03-21) In Vitro Evaluation of the Effect of Polymer Concentration on the Mechanical Properties and Drug Release of Dextromethorphan Hydrobromide from Polyvinyl Alcohol Cryogels

(T1030-03-21) Interactome between Exopolysaccharide, Poly-(1- > 6)-β-N-acetylglucosamine and Proteins in Staphylococcus Epidermidis Biofilms by Live Cell Proximity Labeling

(T1130-03-15) Development of a 96-Well Microplate Reader-Based Method for High-Throughput Screening of Antiplatelet Effects in Rat Platelet-Rich Plasma for Drugs and Herbal Components

(M1130-03-15) Method Development and Validation of Liquid Chromatography–Tandem Mass Spectrometry for SLP-1A6 in Rat Plasma

(W1130-03-15) NGS-Based Platform for Detecting Lentiviral Insertion Sites and Genomic Integration

(W1130-03-16) Homologous Recombination Is Essential for DNA Damage-Induced Regeneration of Germline Stem Cells in the Drosophila Testis Niche

(T1130-03-16) Integration of RNA-Seq and ATAC-Seq Unveils Chromatin Accessibility and Gene Expression Changes in Acute Myeloid Leukemia Cells

(T1130-03-17) A Novel Simulated Plant Based IVG Cervical Mucus Formulation for Sperm Functional Assays with Optimized Spinnbarkeit and Viscosity

(M1130-03-17) Growth and Differentiation Factor 5: A Therapeutic Path for Chondrogenic Progenitor Cell-Based Cartilage Regeneration to Prevent Post-Traumatic Osteoarthritis

(W1130-03-17) Molecular Dynamics Insights into Cryoprotectant-Mediated Stabilization of Amphotericin Liposomes During Freeze-Drying: A Comparative MD and SA-MD Study

(M1130-03-18) Development of Multitargeted Inhibitor, IND-2, for Prostate Cancer Therapy

(T1130-03-18) Next-Generation Sequencing Based RNA-Seq Discover the Differentially Expressed Genes and Pathways of Systemic Lupus Erythematosus

(W1130-03-18) Study on the Anti-Lipid Accumulation Effects of Compounds Derived from Herbs Based on High-Throughput Intracellular Lipid Droplet Phenotypic Analysis

(W1130-03-19) A Novel Plant-Based Orally Disintegrating Films Platform Using Hydroxypropyl β-Cyclodextrin for Pharmaceutical Product Development of Poorly Soluble Drugs

(M1130-03-19) Targeting LSD1 Results in the Upregulation of ASGPR1, Offering a Promising Avenue to Improve the Therapeutic Potential of LYTAC-Driven Extracellular Protein Degradation in Liver Cancer

(T1130-03-19) Ultrasensitive LC-MS/MS Method Enables a Thorough Pharmacokinetic Investigation of Low-Dose Semaglutide Following Oral and Subcutaneous Administration in Healthy Subjects

(W1130-03-20) Discovery of Mitochondria Targeted Non-apoptotic Cell Death Inducers against Resistant Triple-Negative Breast Cancer

(T1130-03-20) Enhancing Drug Penetration Across the Blood Ocular Barrier Using Peptide Transporters: Expression and Pharmacokinetic-Based Analysis

(M1130-03-20) Transport Characterization of Tramadol in an Ex Vivo Blood-Brain Barrier Model Based on Microimpalement of Vessels

(T1130-03-21) From Disorder to Order: Structural Evolution of Solid-State Phases in Pravastatin Sodium via a Liquid Crystalline State

(M1130-03-21) Mitigation of Non-Specific Adsorption of Peptides using Inert Surfaces

(M1230-03-15) Biotin-Targeted Pluronic/Bile Salt Mixed Micelles for Enhanced Bioavailability of Therapeutic peptide

(W1230-03-15) Development of a Plate-Based Assay for the Quantitation of Tenecteplase Activity in Plasma Samples

(T1230-03-15) In Silico Screening Study of Potential Flavonoids as ADAMTS-5 Exosite Inhibitors for the Treatment of Knee Osteoarthritis

(W1230-03-16) Evaluation of the Selectivity of In Vitro Dissolution Absorption System 2 (IDAS2) Through Immediate-Release and Immediate-Extended Bilayer Formulations of BCS Class I Drugs

(T1230-03-16) Formulation and Characterization of Spray-Dried Dermaseptin for Pulmonary Delivery in Lung Cancer Therapy

(T1230-03-17) Meta-Analysis of the Across-Species Pharmacokinetics of Metronidazole with a Minimal Physiologically-Based Pharmacokinetic Model

(W1230-03-17) Peptide-Based Nanoplatform for Improved Cas9 RNP Delivery and Editing

(M1230-03-17) Stabilizing mRNA Lipid Nanoparticles for Aerosolized Delivery Using Excipients

(T1230-03-18) Lateral Transport in Anisotropic Membrane during Permeation Study with Diffusion Cell

(M1230-03-18) Whole Genome Sequencing and Analysis of Manzamine Producer Micromonospora sp. M42

(T1230-03-19) Comparative Evaluation of the Efficacy of Two Novel Trifunctional Compounds for Glaucoma

(M1230-03-19) Mechanistic Insights into Mitochondrial Targetability of PEGylated Fluoroalkyls in Drug Delivery

(W1230-03-19) Pharmacokinetics and Biodistribution of FVIII Containing LysoPS Nanoparticle Following IV Administration

(T1230-03-20) A Novel Trifunctional Donor Enhances Nrf2 Activation and Preserves Retinal Integrity Under Oxidative Stress

(W1230-03-20) AI in Action: Accelerating Co-Crystal Design Using Machine Learning

(M1230-03-20) Pathological and Demographic Determinants of SARS-CoV-2-mediated Dysregulation of Drug Processing Pathways

(T1230-03-21) Application of Lecithin (PL90) and Poloxamer 188 in SLC Transporter-Mediated Drug Interaction Studies

(W1230-03-21) Biological Evaluation of zq-1-68, a Novel Dual-Targeting Tubulin/HDAC Inhibitor in Metastatic Castration-Resistant Prostate Cancer

(M1230-03-21) Enhancing Bioanalytical Lab Efficiency and Compliance Through an Integrated Lab Execution System (LES)

(M1330-03-15) Extracellular Vesicle Transcriptomic Analysis for Understanding Muscle Aging under the Influence of Microgravity

(T1330-03-15) Prediction of DNA-Targeting Anti-Cancer Therapeutics Using Machine Learning-Guided Molecular Docking

(M1330-03-16) Benchtop MALDI Imaging of Human Tonsil Proteins Using IHC Probes

(T1330-03-16) Implementing the Latest Available Technologies in High Throughput through In Vitro ADME DMPK

(M1330-03-17) Harnessing Mass Spectrometry Approaches to Quantify Glycan Composition at the Blood-Brain Barrier

(T1330-03-18) Development of a Pulsed Current Iontophoresis System for Transdermal Administration of Palonosetron Hydrochloride: Exploring the Potential for a Shift Toward At-Home Medical Care

(M1330-03-18) Permeability of Small Molecular Weight Compounds and Macromolecules through Ex Vivo Rabbit Ocular Tissues

(M1330-03-19) Development and Validation of a UPLC Assay for Quantification of a Novel Anti-CRPC Agent PC257 for Preformulation and In Vitro Metabolism Studies

(T1330-03-19) Targeting T-Cell Exhaustion in 3D-Patient-Derived Triple Negative Breast Cancer Organoids and PDx Mice Models Using Novel Calcium Nanoparticles

(M1330-03-20) RP-HPLC Method Development for the Simultaneous Estimation of Trazodone and Gabapentin in Bulk Drug

(T1330-03-20) Synthesis, Structural Characterization, and Inhibitory Effects of Caffeic Acid Phenethyl ester (CAPE) Derivatives on Human Multiple Myeloma Cell Growth

(M1330-03-21) Discovery of Pan-EphB Tyrosine Kinase Inhibitors to Reverse Metabolic Syndrome in Obese Mice

(T1330-03-21) Ultrasound Responsive Violacein Loaded Liposomes for Sonodynamic Therapy against Broad-Spectrum Bacteria and Melanoma: In Vitro Studies

(T1430-03-15) Identification of EphB1/2 Tyrosine Kinase Inhibitors for Chemotherapy-Induced Peripheral Neuropathic Pain

(T1430-03-16) Evaluation of a Toll-Like Receptor 7/8 Antagonist for Anti-Inflammatory Immunotherapy

(T1430-03-17) High-Throughput, Multiplexed CRISPR-Cas13a Assay for Simultaneous Detection of Tuberculosis, HIV, Malaria, and TB Drug-Resistance Markers Using CARMEN

(M1430-03-17) Novel Synergistic TKI Combination Induces Immunogenic Cell Death in Colon Cancer with BRAF and KRAS Mutations

(M1430-03-18) Developing a Liposomal Ciprofloxacin Formulation Using Passive and Active Loading Strategies for Enhanced Ocular Delivery in Bacterial Endophthalmitis

(T1430-03-18) Effect of Intranasally Administered Midazolam, Diazepam or Lorazepam on Neuroinflammation in Acute Seizures Mice

(M1430-03-19) Exploring Mitochondrial Involvement in Persistent Fat Accumulation of Lipedema

(T1430-03-19) Selenium-Functionalized Sulfated Hyaluronic Acid (sHASe): A Novel Multi-Targeted Therapeutic Strategy for Overcoming Therapy Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma

(T1430-03-20) A Rationally Designed Orally Active Peptidomimetic-Targeting EGFRs for Non-Small Cell Lung Cancer

(M1430-03-20) Enhancing Oral Bioavailability in Preclinical Dog PK Studies Using Ball Milling Technology

(M1430-03-21) In Vitro Evaluation of Polyvinyl Alcohol (PVA) Cryogels for Sustained Release of Anionic and Cationic Drugs

(T1430-03-21) Role of Co-Occurring Herbs on Toxicity of Radix Aconiti Lateralis Containing TCM Formulae

(T1530-03-15) Dual Immunomodulatory and Neuroprotective Effects of Urea-Based Soluble Epoxide Hydrolase Inhibitor

(M1530-03-15) Evaluating Physicochemical Properties of Cyclic Peptides and Their Interactions with Bile Acids Using Micellar Electrokinetic Chromatography

(T1530-03-16) A Comparative Study of Product Recovery in Laboratory-Scale Spray Dryers: Standard Cyclone vs. the Discovery Module

(M1530-03-16) On-Demand Endogenous Nanoparticle Based Cargo Loading of Extracellular Vesicles for Therapeutic Delivery

(T1530-03-17) Lattice Based Model to Study Drug Diffusion through Excipient Matrix

(M1530-03-17) Unveiling PNAG Dynamics in Bacterial Biofilms through Microfluidics and Fluorescence Microscopy

(M1530-03-18) A Novel Therapeutic Approach for Treatment of Taxane-Resistant Prostate Cancer

(T1530-03-18) Ionic Liquid-Based Dissolving Microarray Patches for Controlled Release of Isoniazid: A Proof-of-Concept Study

(T1530-03-19) Respiratory and Genomic Effects Induced by Phosphine Gas Exposure: Insights from Mouse Model to Identify Therapeutic Targets

(T1530-03-20) Evaluation of Histone Deacetylase-6 (HDAC-6) Inhibitor Tubacin on 3D Midbrain Neurospheres: A New Therapeutic Avenue for Parkinson’s Disease

(M1530-03-20) Overcoming Intracellular Delivery Challenges of Small- and Large-Molecule Through First-in-Class Macropinocytosis Activators

(T1530-03-21) Study on the Immunomodulatory Effect of Major Plasma Components of Fufang Shengdi Granules in Imiquimod-Induced Psoriasis Mice

(M0930-06-34) Encapsulation of Bacteriophages in Liposomes for Improved Inhaled Delivery

(T0930-06-36) Development of Injectable Chitosan-Based Hydrogels for Sustained Bladder Delivery of Therapeutic Proteins

(M0930-06-38) Engineering Next-Generation Ionizable Lipid Nanoparticles for siRNA Therapeutics: Insights from a DoE Optimization Strategy

(T0930-06-38) Evaluating the Immunogenicity of Painless Microneedle Microparticulate Combination Vaccine for COVID-19 and Flu

(M0930-06-40) Investigating the Outcomes of Trehalose Crystallization in Lyophilized Protein Systems

(W0930-06-40) PAIex: A Virtual Expert Tool for Enhanced Pre-Approval Inspection Preparedness

(M0930-07-41) Use of 5% Dextrose Intravenous Diluent for Therapeutic Monoclonal Antibodies: Impact on Mabs Under Varying Formulation Conditions

(T0930-07-42) Tumor-Targeting Polymeric Micelles for Nose-to-Brain Delivery of Near-Infrared Imaging Agents for Optical Image-Guided Brain Surgery

(M0930-07-43) Dual-Action Core-Shell Nanofibres: Integrating Rapid Antimicrobial Release and Sustained Insulin Delivery for Diabetic Wound Healing

(W0930-07-46) Harnessing Vanillin for Development of 3D Printable Chitosan/β-Glycerophosphate Hydrogels

(T0930-07-47) Pharmacokinetic Study of the Effect of Buffer on Long-Acting Injectable Formulations

(M0930-08-48) Comparative Evaluation of Automated Protein Purification Technologies

(W0930-08-48) Development of a Controlled-Release Diphenhydramine HCL Tablet Using HPMC-Based Hydrophilic Matrix Technology

(T0930-08-48) Development of a Novel Stabilizer for Biotherapeutic Antibody Formulations with Residual Lipase Activity

(M0930-08-49) Multimodal Characterization of Protein–Protein Interactions in Monoclonal Antibodies Using k_D, B₂₂, and DLVO

(T0930-08-49) Solving PK Challenges- Inhaled Peptide-Drug Conjugates Allow for Tunable PK Profiles, Maximizing Efficacy Whilst Reducing Dose and Dosing Frequency

(W0930-09-55) Design of Site-Specific Enteric Capsule for Terminal Ileal Drug Delivery

(T0930-09-55) Micellar Oligo(Lactic Acid)8-Doxorubicin Formulation Enhances Antitumor Efficacy and Reduces Toxicity in a TNBC Model Compared to Free Doxorubicin

(M0930-09-55) Spray-Dried Inhalable RNA-Lipid Nanoparticles for Pulmonary Delivery

(T1030-06-37) Engineering Tumor and HEK Cells to Produce Multi-Targeted Exosomes: A New Frontier in Targeted Checkpoint Therapy

(T1030-06-38) Paving the Road to Use saRNA Loaded into Polymeric Nanoparticles as Nanovaccines Platform to Target Glioblastoma

(W1030-06-39) Impact of Ionizable Lipid Source on the In Vitro Performance of siRNA Loaded Lipid Nanoparticles

(T1030-06-39) Next-Generation Gene Delivery: Integrating Lipoplex Technology with Trehalose-Stabilized Dissolving Microneedle Arrays

(W1030-07-41) Effective Delivery of Cyclosporine Prevents Immune-Vascular Balance in Lupus in the MRL-lpr Mouse Model

(M1030-07-41) Elucidating Immunomodulatory Mechanism of Bifunctional Peptide Inhibitors Using Mouse Model of EAE

(W1030-07-42) Buffering for Contraception: A QbD-Guided 3D Printed Vaginal Film for On-Demand, Hormone-Free Protection

(T1030-07-42) Follicular Delivery of 4-phenylbutyric Acid PLGA Nanoparticles to Mitigate Chemical Warfare Agent-Induced Skin Injury: A Quality by Design Approach

(T1030-07-44) Development of a 3D-Printed Hydrogel Pill Encapsulating Bioengineered Microorganisms for On-Demand Therapeutic Protein Production

(M1030-07-44) Engineering of Thin-Film Freeze-Dried Monoclonal Antibody Powders with Enhanced Flow Properties for Vacuum Drum Filling into UniDose Nasal Spray System

(W1030-07-45) A Novel Basic Charge Variant Observed in Late-Stage mAb-1 Identified as High Molecular Weight Species

(T1030-07-47) Fluorinated Cationic Polymers as Nanocarriers for Intracellular Delivery of Genes and Proteins

(W1030-08-48) Drug Loaded Spanlastics in 3D Bioprinted Hydrogels for Chemotherapy

(M1030-08-48) Effect of Semi-Synthetic Bases and Hydrophile-Lipophile Balance of Mixed Surfactants on Ibuprofen Suppository Release Profiles

(T1030-08-48) Pharmacokinetic Modulation of PLD1 Inhibitor via Exosome Delivery: Enhanced Brain Retention for Alzheimer’s Disease Treatment

(T1030-08-49) Combination of Hydroxypropyl-Beta-Cyclodextrin and Trehalose for Improved Stability of Spray-Dried Monoclonal Antibodies

(M1030-08-49) Polymers as the Stabilizing Excipient for Spray-Dried Solid-State Protein Formulations

(T1030-08-54) Evaluation of Glycerol and Sorbitol in Preventing Aggregation of Monoclonal Antibodies under Mechanical Stress

(W1030-09-55) Aggregation of a Trastuzumab Radioimmunoconjugate under Handling Stress

(T1030-09-55) Lyophilized Formulation Screening to Improve Physical and Biological Stability of siRNA-Loaded Lipid Nanoparticles

(M1030-09-55) Targeted Intranasal Delivery of pApoE2 via Exosome-Polymeric Micelle Hybrid Nanocarrier Attenuates Neuroinflammation in Aged Mice

(W1130-06-35) Innovative Multilayer VitalDose® EVA Implants for Controlled and Sustained Release of Goserelin Acetate

(M1130-06-35) Sustained Delivery of 4-Phenylbutyric Acid through Chitosan Nanoparticles in Foam Formulation for Decontamination and Treatment of Chemical Warfare Agent-Induced Skin Injury

(M1130-06-40) Extraction, Characterization and Biodistribution of Plant-Derived Exosomes for Drug Delivery

(W1130-07-42) Inhaled Delivery of Synergistic Alginate Lyase-Ceftazidime Combination to Eradicate Pulmonary Pseudomonas aeruginosa Biofilms

(W1130-07-43) Urolithin-A Laden Nanoparticles Attenuate Cisplatin-Induced Systemic Toxicity: A Comparative Study in Aged and Young Mice

(T1130-07-44) Encapsulating Vaccines via Spray Drying: Achieving Thermostability and Controlled Delivery for a Single-Shot Vaccination Strategy

(M1130-07-44) Melt-Extruded Paclitaxel Nanocrystal-Loaded Fibers for Local Chemotherapy with Sustained Antitumor Activity

(M1130-07-46) Evaluating Stability and Permeation of Exenatide in the Presence of Trehalose and Mannitol, Optimizing Aerodynamic Parameters for Engineered Mannitol as Carrier for Pulmonary Delivery

(W1130-08-48) Albumin Corona Improves Colloidal Stability of Nanosac: A Non-cationic Polyphenol Gene Carrier

(M1130-08-48) Development of Buccal Miconazole Nitrate Tablets via Hot-Melt Extrusion for Enhanced Solubility and Mucosal Delivery

(T1130-08-48) Orally Dissolving Films (ODFs): A Modern Solution for Convenient Drug Delivery

(M1130-08-49) Understanding Stabilization Potential of Polymeric Excipients for Spray-Dried Monoclonal Antibody Formulations

(W1130-09-55) Investigating the Protective Effects of Multifunctional Nano Herbal Gel for Wound Healing

(T1130-09-55) Systemic Delivery of siRNA to Solid Tumors with Nanopuff Polyphenol Nanoparticles

(M1130-09-55) Unraveling the Impact of Ionic Strength on Antibody Self-Association Using a Novel QCM-D Approach

(T1230-06-34) Enhanced Oral Delivery of Cyclosporine A Using GA- and NAR-Modified Nanoparticles in a Collagen-Induced Arthritis Mouse Model

(M1230-06-35) Development of a 4-Day Lidocaine Microreservoir Transdermal Delivery System

(M1230-06-36) In Situ Forming Implants: The Effect of Drug-Polymer-Solvent Interplay on Depot Behavior

(T1230-06-37) Development of Chitosan-Coated Indole-3-Acetic Acid Nanoparticles: A Novel Nano Formulation Approach

(W1230-06-38) Polysorbate Hydrolysis and Protein Stability: Investigating the Role of Free Fatty Acid Particles

(T1230-07-42) Fabrication of PVA Microneedles Using Vacuum Compression Molding for Three-Day Transdermal Delivery of Palonosetron Hydrochloride

(T1230-07-43) Advancing Oral Delivery of Biologic Drugs: Strategies to Overcome Formulation Challenges with Permeation Enhancers

(T1230-07-44) Leveraging Protein as a Local Buffering Agent to Safeguard Probiotics in Alginate Encapsulates during Gastric Transit

(M1230-07-45) Development of CXCR4 Targeted Polymeric Polyplexes for Delivery of MicroRNA Therapeutics in Alcohol Associated Liver Disease Treatment

(W1230-07-46) Degradation Kinetics during Hydrolysis of PEG Fatty Acid Esters in Antibody Formulation in Comparison to the Commonly Used Polysorbates

(M1230-08-48) Antibody-Targeted Liposomes Encapsulating Indocyanine Green Aggregates for Photoacoustic Imaging (PAI) and Image-Guided Drug Delivery

(W1230-08-48) Beyond Specificity: Evaluating the Cross-Protective Potential of a Whole-Cell Inactivated Microparticulate Gonorrhea Vaccine

(T1230-08-48) Non-Invasive Mechanical Disruption of Adipocytes via NIR-Triggered Gold Nanoparticle/Perfluorohexane Synergistic Cavitation: A Safe and Targeted Fat Reduction Strategy

(M1230-08-49) High-Concentration Protein Formulations: Mechanistic Understanding of Hydroxypropyl-β-Cyclodextrins Mitigates Viscosity Challenges

(T1230-08-49) Microfluidic Synthesis of pH- and Ca^2+- Responsive PNAG Microparticles

(W1230-09-55) Formulation Development of Novel T-Cell Targeting Ligand-Conjugated Lipid Nanoparticles for In Situ CAR-T Cell Therapy Using Model mRNAs

(M1230-09-55) Impact of Freezing Process and Trehalose Concentrations on T-Cell Cryopreservation

(T1330-06-36) Urolithin A-Laden P2Ns-GA Enhances Anticancer Efficacy in Cisplatin-Resistant Ovarian Cancer and Mitigate Nephrotoxicity in a Murine Model

(T1330-06-37) 3D Printed Buccal Film Having Microparticulate COVID-19 Vaccine Delivered by Heterologous Strategy

(T1330-06-40) Minimizing Mycobacteriophage Titer Loss During Inhaled Delivery by Developing Inhalable Phage Powders

(T1330-07-42) Polymer-Based Implant for the Sustained, Controlled Release of Antisense Oligonucleotides for the Treatment of Chronic Conditions

(T1330-07-43) Engineered Nanobody-Bearing Exosomes Enable Precision Trop2 Knockdown in Resistant Breast Cancer

(T1330-07-44) Brain Targeted Delivery of siRNA Incorporated Polymeric Nanoparticles with PEG and Polysorbate 80 Surface Modification for Global Cerebral Ischemia

(T1330-07-46) Evaluation of Next-Generation Lipids with Varying Chemistries for Enhancing the Endosomal Escape and Extrahepatic Delivery Potential of mRNA-LNP Therapeutics

(M1330-08-48) Cellular Protective Mechanisms in ER Stress and Prolonged Ocular Retention of αB-crystallin-ELP Fusion Peptides

(M1330-08-49) Aggressive But Controlled: Pushing the Limits of mAb Freeze-Drying in an 8-Hour Cycle

(T1330-08-49) Biodistribution and Prolonged Respiratory Retention of Fluorescently Labeled IgM Antibody Intranasally Administered in Mice

(T1330-09-55) Early Development of Lipid Nanoparticles as Carriers for miRNA

(M1330-09-55) Process Optimization of Preparing Lysozyme-Loaded Liposomal Dry Powder via Design of Experiments

(M1430-06-34) Development of a Novel Fast Dissolvable Microneedle-Based Delivery System for the Next-Generation Influenza Nanovaccine

(T1430-06-34) Improving Doxorubicin’s Tumor Penetration and Retention by Discrete Multiwalled Carbon Nanotube-Based Drug Delivery

(T1430-06-35) Fibronectin CS1-Conjugated Polymeric Micelles for Rapamycin Delivery and Modulation of Pro-Inflammatory Cytokines in Alzheimer’s Disease

(M1430-06-37) Successful Transfection of Dendritic Cells by eGFP mRNA-Containing Lipid Nanoparticles

(M1430-07-41) Endometrium-Targeted mRNA-LNPs for the Treatment of Infertility

(M1430-08-48) Hot-Melt Extrusion Enabled Amorphous Solid Dispersions: A Comparative Study of Binary and Ternary Polymer Systems for Solubility and Dissolution Enhancement

(T1430-08-48) Optimizing Biologics Formulation: Synthetic Sugars for Improved Stability and Viscosity

(M1430-08-49) Preparation, Characterization, and Evaluation of Cellular Uptake of Spray-Dried Albumin Nanoparticles

(T1430-09-55) Development of Analytical Tools for Investigating Drug-Device Interactions: A Case Study on mAb Stability and Silicone Coating Integrity

(M1430-09-55) Process Change in Cell Culture Significantly Improves Aggregates in Drug Product

(T1530-06-35) Brain-Targeted ApoE2 Gene Delivery Across the Blood-Brain Barrier using Dual-functionalized Liposomal Nanoparticles for Alzheimer's Disease Therapy

(M1530-06-35) COG133 Peptide-Conjugated Lipid Nanoparticles Sensitize Medulloblastoma to Radiation Therapy in Mice

(T1530-06-36) Oral Delivery of Anti-TNF-α Antibody via Pickering Emulsion for Ulcerative Colitis Therapy

(M1530-06-37) Effective Methods for Ensuring Dose Accuracy in Low Volume Drug Transfers Using Closed System Transfer Devices

(M1530-07-42) Bilayer Buccal Vaccine Film with 3D-Printed Application Control for Ambient-Stable Delivery and Mucosal Immune Activation

(M1530-07-43) Breaking Through the Barrier: 3D-Printed Microneedles Unlock Superior Transdermal Delivery of 5-Fluorouracil and Genistein for Melanoma Treatment

(T1530-07-46) Mechanistic Differences of NaCl vs. MgCl₂ in Preventing AAV8 Capsid Aggregation

(M1530-08-48) End Group Chemistry Modulates Physical Properties and Biomolecule Release from Biodegradable Polyesters

(T1530-08-48) Significant Antiasthmatic Effect of Receptor-Guided Parenteral RNAi-Loaded Polymeric Nanocarriers in Murine Asthma Model

(M1530-08-49) In Vivo Investigation of Double TLR4-TLR9 Activating Nanocomplexes for Cancer Immunotherapy

(T1530-09-55) A Therapeutic Strategy with Inhalable Polydopamine-Based Nanocarrier for Nintedanib in Managing Idiopathic Pulmonary Fibrosis

(M1530-09-55) Machine Learning-Enabled Morphological Profiling of Primary T Cells Subjected to Forced Degradation for Quality Control Applications

(W0930-06-34) Ultraflexible Liposomes Enhance Topical Delivery of ADT-007 for Potential Melanoma Therapy

(M0930-06-35) Dissolving Microneedles Based on Carboxylmethylcellulose and Surfactant Systems for Enhanced Delivery of Itraconazole

(T0930-06-35) Feasibility and Application of Anti-Malarial Endoquine-Like Quinolone (ELQ) on Mosquito Bed Nettings and HDPE Films for Anti-Malarial Properties using Solution Coatings and Hot Melt Extrusion Methods

(W0930-06-35) Formulation and Development of Haloperidol Implants for Patients with Schizophrenia

(M0930-06-36) Development and Evaluation of Ribociclib-Loaded Folic Acid Conjugated Chitosan-Polycaprolactone Nanoparticles for the Management of Glioblastoma

(W0930-06-36) Pulmonary Delivery of Drug-Loaded Superparamagnetic Iron Oxide Nanoparticles for Diagnosis and Treatment of Tuberculosis

(W0930-06-37) Artificial Intelligence to Predict Drug Release from Sustained-Release Coated Tablets

(T0930-06-37) Developing Lipid Based Nano Drug Delivery System (LBNDDS) of Osimertinib in Combination with Curcumin Using Design of Experiment (DoE) for Enhanced Permeability and Release Effect

(M0930-06-37) Investigation of 3D Printed Structures Employing Triply Periodic Minimal Surface (TPMS) Topology for Poorly Soluble Drugs: Part I - Development of 3D-Printed Hypromellose Structure with Ibuprofen

(W0930-06-38) Optimized Platform-Based Formulation Strategies Can Accelerate Drug Development for Targeted Delivery: From Process Design to Performance Evaluation

(W0930-06-39) Can Molecular Descriptors Drive Nanosuspension Innovation? Leveraging Machine Learning and AI to Predict the Particle Size

(M0930-06-39) Developing Multiple Strengths of Controlled Release Tablet Formulations

(T0930-06-39) Stability of Nifedipine Amorphous Solid Dispersions (ASDs) with Low Drug Loading in Rodent Chow

(T0930-06-40) Extra-Large Spray-Freeze-Dried Particles Achieve Significant Salbutamol Fine Particle Fraction for Pulmonary Delivery

(W0930-07-41) Analysis of the API Sustained-Release Mechanism of Hyaluronic Acid Nanogel (HA nanogel) Formulation

(M0930-07-42) Beyond Particle Size: Impact of Milling Techniques on Agglomeration Behavior and In Vitro Performance of Long-Acting Injectable Suspensions

(W0930-07-42) Development of a Drug-Eluting, 3D-Printed, Injectable Intraocular Lens for Glaucoma Treatment

(W0930-07-43) 3D-Printed Microfluidic vs Conventional Fabrication of P(DMAEMA-co-SMA)-Based Lipopolyplexes: A Comparative Study of Stability, Morphology and Cytotoxicity

(T0930-07-43) Voriconazole Nanosuspension-Loaded Microneedle Patch for Fungal Keratitis

(T0930-07-44) In Vitro Deposition Studies of Microparticulate Nasal Powders

(W0930-07-44) Spray-Dried Solid Dispersions of Edaravone for Enhanced Oral Delivery

(W0930-07-45) Development of a High Drug-Loaded Sustained Release Tablet of a Highly Water-Soluble Drug Using Kollidon® SR via Twin Screw Melt Granulation

(M0930-07-45) Predictive Stability Modeling of Softgels

(T0930-07-46) Biodegradable, Hormone-Free Thermoresponsive Vaginal Gels for On-Demand Contraception Using Low-pH Block Copolymer Systems

(M0930-07-46) Enhancing the Solubility of Sotorasib (AMG-510) with the Acid-Base Supersolubilization (ABS) Approach to Formulate ASDs by Hot Melt Extrusion

(M0930-07-47) In Situ Measurement of Multiple Chemical Compound Species in Dissolution Medium Using a Fiber Optics UV Spectrometer

(W0930-07-47) The Importance of Microcrystalline Cellulose Selection for Fluid Bed Wet Granulation

(W0930-08-49) Engineering Biodegradable Polymer–Drug Conjugates for Precision Oncology Nanomedicine

(M0930-08-50) Engineering Stimuli-Responsive Hierarchical Nanogels for Programmable Pulsatile Oral Vaccine Delivery

(W0930-08-50) Formulation Process Development of a Novel Combination Analgesic Based on Risk Assessment (RA) and Design of Experiments (DoE)

(T0930-08-50) Polymer Coated Solid Injectable Dispersions for Long-Acting Delivery of Tenofovir Alafenamide

(M0930-08-51) Design and Evaluation of 3D Printed Hydrophilic Transdermal Films of Pramipexole Dihydrochloride Using PVA Variants

(T0930-08-52) Biorelevant Imaging and Formulation-Specific Release Prediction for the Rapid Assessment of Long-Acting Injectables

(M0930-08-52) Improving Solubility of Poorly Soluble Active Pharmaceutical Ingredients:The Impact of Plasticizers in Melt-Based Amorphous Solid Dispersions with Polyvinyl Alcohol

(W0930-08-52) Influence of Curing Conditions on the Functional Integrity of Aqueous and Solvent-Based Approaches for Enteric Coating

(W0930-08-53) AI/ML Model Informed Early-Stage Drug Development

(T0930-08-53) Modeling Metamorphosis: Advancing Dermal PBPK Modeling – A Metronidazole Case Study

(M0930-08-53) Troubleshooting a Dose Proportional Tablet Formulation

(T0930-08-54) Design of Dissolving Microneedles Based on Amorphous Salt Formation for Controlled Drug Release

(M0930-08-54) Development of a Patient Friendly, Pediatric Formulation of Xalkori Leveraging a Multiparticulate Formulation Approach and Quality By Design Principles

(W0930-08-54) Long Acting In Situ Forming Implants – Hydrogel Phantom Approach and Comparative In Vitro Release Studies

(W0930-09-56) Assessing the Performance of Lipids as Surfactants to Enhance the Release Profile of a Model BCS Class IV Compound from Amorphous Solid Dispersions (ASDs)

(T0930-09-56) Cloudy with a Chance of Precipitation- An Investigation into Physiochemical Incompatibilities between Parabens and Polysorbate 80

(M0930-09-56) Excipient Screening of Long-Acting In Situ Forming Gels during Preclinical Formulation Development

(M0930-09-57) AI-Driven Color Selection for Highly Regulated Pharma and Nutra Markets

(T0930-09-57) Dissolution-Membrane Permeation Combined with Dissolution Imaging for Bioperformance Prediction of Amorphous Solid Dispersion Manufactured by a Novel Co-Precipitation Process

(W0930-09-57) In Vitro Bioequivalence Evaluation of Topical Creams Throughout the Product’s In-Use Shelf Life

(W0930-09-58) Evaluating the Biopredictivity and Robustness of In Vitro In Vivo Correlation (IVIVC) for Acetaminophen Absorption Using TIM Advanced In Vitro Gastrointestinal Models

(W0930-09-59) A Systematic Study of the Plasticizing Effect of Phospholipids with Various Amounts of Hydrogenated Phosphatidylcholine

(T0930-09-59) Population Balance Modeling of Aggregation in Long-Acting Injectable Formulations Integrated with PBPK

(M0930-09-59) Topical MEK Inhibitor Formulations Suppress HPV E6/E7 Expression and Promote Tumor Regression in Preclinical Models

(M0930-09-60) Drugs as Excipients: Evaluation of Colistin, a Cationic Antimicrobial Peptide, as a Multifunctional Stabilizer of Inhalable Niclosamide Microparticles

(W0930-09-60) High Drug Load Nanocrystalline Formulations Matching the Performance of Supersaturating Amorphous Solid Dispersions and Offering Reduced Pill Burden

(T0930-09-60) Poloxamers in Continuous Melt Granulation: Dual Role as a Binder and a Solubilizer

(M0930-09-61) Effective Aerosol Delivery of Dry Powder Inhalers during Mechanical Ventilation: Role of Humidity and Circuit Parameters

(T0930-09-61) Enhancing the Tabletability of Fenofibrate-HPMCAS Amorphous Solid Dispersions Using Kollitab® DC 87 L: A Multifunctional Excipient Approach for Direct Compression

(T1030-06-34) Biogenic Isatin Derivative (TM-19) Loaded Green Silver Nanoparticles Using Citrus Fruit Peel in the Treatment of Fungal Infection: In Vitro and Ex Vivo Studies

(M1030-06-34) Investigating Bioequivalence of Antimalarial Formulations Using In Vitro and In Silico Biopharmaceutics Tools

(T1030-06-35) Design and Development of Dose-Flexible Formulation of Pyrimethamine Using Binder Jet 3D Printing

(W1030-06-35) Development of Terminalia avicennioides Extract-Hyaluronic Acid Hydrogel Formulation for the Treatment of Methicillin-Resistant MStaphylococcus aureus in Wound Infections

(M1030-06-36) Creating an Ultra-Long-Acting Parenteral Atovaquone Prodrug Nanosuspension for Malaria Chemoprophylaxis

(T1030-06-36) Development of Thermoresponsive Tacrolimus Loaded Nanoemulgel for Localized Immunomodulation in Psoriasis

(W1030-06-36) Engineered Oral Nanoparticle Delivery for Metronomic Chemotherapy in a PTX-Resistant Ovarian Cancer Mouse Model: Investigating the Efficacy and Off-target Effects

(W1030-06-37) Investigating the Physical Stability of GENE-A Dry Powder for Inhalation Using Solid-State Techniques

(M1030-06-37) Predicting Drug Release from EVA-Based Long-Acting Implants: Mechanisms, Modeling, and Simulation of Drug Release

(W1030-06-38) Development of Drug in Adhesive-Based Transdermal Patch of Pelubiprofen for Arthritis Treatment

(M1030-06-39) Impact of Polyethylene Glycol Polymer in the Development of Long-Acting Injectable Suspensions

(M1030-06-40) Development and Validation of UPLC Method for Digoxin and Degradants and It's Application to Assess the Effect of Process Variables on Quality Attributes of Digoxin Formulations

(T1030-07-41) A Targeted Drug Delivery System for the Treatment of Colorectal Cancer

(M1030-07-42) Optimization of Perfluorocarbon-Based Oxygen Carriers for Machine Perfusion with Controllable Oxygen Release

(T1030-07-43) Cyclosporine A Nanoparticles Combined with Urolithin A Mitigate Osteoporosis in Ovariectomized MRL/lpr Mice

(M1030-07-43) Long-Term Release Kinetics and Characterizations of Episcleral Silicone Implants for Anterior Segment Ocular Delivery of Ketotifen Fumarate and Cyclosporine A

(W1030-07-44) Investigating the Role of Surfactants and pH Modifiers in Overcoming pH-Dependent Solubility Limitations of Febuxostat, a Weakly Acidic and Poorly Soluble Drug, via Hot-Melt Extrusion

(M1030-07-45) Effect of Drug Properties on the Formation of Amorphous Solid Dispersion

(T1030-07-45) NMR Analysis of Molecular Interactions of Polyoxyethylated Amphiphiles for Solid Micellar-Size Nanoparticles: Probing into the Mechanism of Anti-Dilution Properties

(M1030-07-46) Leveraging Carnitine-Functionalized Lipid Nanocarrier-Based Targeted Delivery of A1874 PROTAC for Glioblastoma

(T1030-07-46) Sustained Release of a Pan-RAF–MEK Molecular-Glue (NST-628): A New Strategy for Long-Acting Cancer Therapy

(M1030-07-47) A Data-Efficient Approach to Design Stable Solid-State Lipid Nanoparticles for Microneedle Application

(W1030-08-49) Solubility and Dissolution Improvement of Gliclazide through Complex formation with Meglumine

(W1030-08-50) Development of Delayed Release Capsule Formulations of a Nutraceutical Active Compound Using Hydrophilic Matrix Systems

(T1030-08-50) Development of Lumefantrine Amorphous Solid Dispersion Using Vertical Hot Melt Extrusion

(M1030-08-50) Enhancing Capsule Swallowability via Double-Layer Design for Superior Glide in Wet Conditions

(W1030-08-52) Optimization of Roller Compaction Process Parameters and Roller Design of Poorly Flowing Powder Blend

(M1030-08-52) Revolutionizing Chewable Tablet Fabrication: A Green, Continuous Approach via Hot Melt Extrusion Integrated with Direct Extrusion-Based 3D Printing

(T1030-08-52) Solid-State Characterization of Crinone^® (Progesterone Vaginal Gel): Microscopy, X-Ray Diffraction, and Thermal Behavior

(T1030-08-53) An Advanced Drug Delivery System for Enhancing Enteric Resistance and pH-Triggered Drug Release in the Duodenum

(M1030-08-53) Evaluation of Talc Alternative for EUDRAGIT^® E PO-Based Coatings

(W1030-08-53) Evaluation of Titanium Dioxide Alternative in Polymethacrylate (EUDRAGIT^® E PO) Based Coatings

(M1030-08-54) ASAPprime®: A Fast-Track Insight to the Stability of Tablets Impacted by Coating

(W1030-08-54) Setting the Benchmark: Enhanced Purification of Polyoxyl 35 Castor Oil Using a Novel In-House Adsorbent System

(W1030-09-56) Investigating the Impact of Variation in Carbomer Homopolymer Type C (Carbopol® 980) concentration on Diclofenac Sodium Gels’ Microstructure and Skin Permeation

(M1030-09-56) Personalized 3D-Printed Tablets for Diabetes and Related Complications: Design, Optimization, and Evaluation

(T1030-09-56) Split Decisions: Tracking Preservative Partitioning in Cream Formulations

(T1030-09-57) Formulation Development of Immediate Release Ilaprazole–Antacid Fixed-Dose Combination Tablets and Pharmacokinetic Evaluation in Beagle Dogs

(W1030-09-57) Improving PROTAC Dissolution via an Ionic Liquid API Approach with Enhanced Solid Handling

(M1030-09-57) Investigation of Nintedanib Formulation Development: Systematic Screening from pH Solubility Assessment to Sodium Fatty Acid Salt-Polymer Optimization

(M1030-09-59) Evaluation of Spray Dried and Nanomilled Formulations on Pharmacokinetics Using Predictive Modeling

(W1030-09-59) Investigation of Advanced Fattigation-Platform Using PLGA-Cystamine-Fatty Acid Conjugates for Effective Tucatinib Delivery

(T1030-09-59) Spray-Dried Amorphous Solid Dispersions of Celecoxib-PVPVA64-SBEβCD Ternary Complexes: Preparation, Flory Huggins Interaction Parameters and Dissolution Enhancements

(W1030-09-60) Effect of Polymer Architecture on Crystal Growth in Amorphous Nifedipine: Bottlebrush vs. Linear Polymers PEGs

(M1030-09-60) Influence of the Biorelevant Media on the Solubility of Benzthiazide, Isoxicam, and Piroxicam in the Presence of Several Excipients

(T1030-09-60) Key Materials Attributes, Process Challenges and Fast-Track Stability Evaluation in Designing the Immediate-Release Formulation for Alzheimer’s and Parkinson’s Disease

(M1030-09-61) Lyotropic Liquid Crystalline Nanoparticles for Gene Delivery: Influence of Composition on Physicochemical Properties, Cellular Uptake, and DNA Encapsulation

(T1030-09-61) Quantitative Differences in Carbomer Homopolymer Type B and Its Effect on the Structural and Permeation Characteristics of Diclofenac Sodium Topical Gels

(W1030-09-61) Study on Solid Dispersion by High Shear Granulation Using HPMC and HPMCAS as Carrier

(T1130-06-34) Mitochondria-Targeted Delivery of Metabolic Modulators to Tumor-Associated Macrophages for Immunotherapy

(M1130-06-34) The Particle Drifting Effect In Vivo: Impact of Dose and Animal Species

(W1130-06-34) Topical Liposomes for the Treatment of Fuchs Endothelial Corneal Dystrophy (FECD) Obviating the Need for Surgery

(T1130-06-35) Dual-Action Nanotherapy Reduces Ocular Inflammation in Mice with Systemic LPS-Induced Uveitis

(T1130-06-36) Aging of Viscoelastic Organogels Designed as Platforms for the Prevention of Bovine Mastitis

(W1130-06-36) Investigation on Role of Penetration Enhancers to Improve Topical Permeability of Clotrimazole

(M1130-06-36) Tracking the Microstructural Changes and Degradation Behaviors of Bioresorbable Subdermal Pellets Under In Vitro and In Vivo Conditions

(T1130-06-37) Abacavir/Lamivudine Nanobased Fluid Gel System for Paediatric Antiretroviral Therapy

(W1130-06-37) Data-Driven Formulation of Solid Oral Dosage Forms: Computational Modeling to Experimental Validation Using ZoomLab^TM

(M1130-06-37) Revolutionizing Women’s Health by Enabling the Rational Development of Long-Acting Contraceptive Levonorgestrel Intrauterine Systems

(T1130-06-38) Achieving Sustained Supersaturation of Poorly Soluble Naringenin through Cocrystal Engineering

(W1130-06-38) Formulation of a Teixobactin-Lipopeptide Hybrid as an Inhalable Dry Powder for the Treatment of Pulmonary Pan-Drug Resistant Bacterial Infections

(M1130-06-38) Real-Time PAT Monitoring of Coating Process in the Design and Optimization of a Dose-Flexible Tolfenamic Acid Dosage Form for Cancer Indication

(M1130-06-39) Biosustane as a Novel Oral Excipient for Solid Dosage Forms – Formulation Development, Characterization, and IVIVC Prediction

(W1130-06-39) Development of In Vitro Release Testing and In Vitro Permeation Testing Methods to Study the Impact of Quantitative Differences in Carbomer on the Performance of Diclofenac Sodium Topical Gels

(T1130-06-39) Transdermal Bilayer Microneedle Array Patches (MAP) for Pediatric HIV Therapy: Investigating Wear Time and Islatravir Delivery Efficiency

(T1130-06-40) Extending the Tabletability Mixture Model to Poorly Compressible APIs

(M1130-07-41) Development and Verification of Novel Agarose Gel Based Dialysis Cassette System as an In Vitro Release Model for Long-Acting Injectable Formulations

(W1130-07-41) Inhale It: Heterologous Intranasal Delivery of a SARS-CoV-2 Microparticle Vaccine

(T1130-07-41) Intratumoral Delivery of Lapatinib via pH-Responsive Liposomes Embedded in a Thermosensitive In Situ Hydrogel: A Potential Chemotherapeutic Modality for Breast Cancer

(M1130-07-42) Prevention of Lung Cancer Using Bio-Enhanced Sulfasalazine and Disulfiram Nano Self-Emulsifying Drug Delivery System Platform: Formulation Development, Pharmacokinetics, and Biodistribution Study

(T1130-07-42) Triple Functionalized Liposomes for Improved Penetration and Targeting of VGF Gene Across BBB in Alzheimer's disease Management

(M1130-07-43) Formulation Development of Oral CBD-Loaded SEDDS with Optimized Dissolution and Digestive Performance

(T1130-07-43) Vortioxetine-Loaded Liposomes: A Repurposed Approach for Glioblastoma Therapeutics

(W1130-07-44) Bioadhesive-Drug Powder Mixtures for Improved Local Delivery to the Nasal Mucosa

(T1130-07-45) Formulation of Acetaminophen Chewable Tablets Using Carrageenan

(M1130-07-45) Optimizing Solution Performance Through Solid Form Diversity – A Study of Naringenin:Tetramethyl Pyrazine Cocrystals

(W1130-07-45) Solubility Enhancement of Ibuprofen via Crystalline Solid Dispersions: A Comparative Study of Carriers and Optimization Using DoE

(W1130-07-46) Evaluation of Stability and Functional Packaging Effectiveness for Ferrous Ascorbate Tablets Coated with Aqueous Moisture Barrier Film Coating Formulation

(T1130-07-46) ZoomLab^®-Enabled Development of Directly Compressible Solid Dosage Forms with a Novel Co-processed Excipient

(M1130-07-47) Downstream Processing of Spray Dried Amorphous Solid Dispersions via Roller Compaction

(W1130-08-49) Liposomal Co-delivery of Luteolin and Piperine for Enhanced Lung Cancer Cell Death: In Vitro Characterization and Anticancer Activity

(W1130-08-50) Development of Long-Acting Injectable Formulations of Next Generation Diarylquinolines for Preventive Therapy of Tuberculosis Infection

(T1130-08-50) Influence of Nanoparticle Composition on the Dutasteride Follicular Accumulation

(M1130-08-50) Personalized Drug Delivery via 3D-Printed Tablets: Optimizing Patient-Specific Release Kinetics Using a Central Composite Design

(M1130-08-52) Development of Organic Solvent-Free Amorphous Solid Dispersions of Felodipine with PEGs via Supercritical CO₂ Processing: A Green Strategy for Enhanced Dissolution and ODT Formulation

(T1130-08-52) Identification of Formulation Design Space for Quetiapine Fumarate Extended-Release Tablets across Strengths

(W1130-08-52) Optimizing Compression Pressure for Disintegration Efficiency in ODTs: A Formulation Strategy Using F-MELT^® Platform Technology

(W1130-08-53) Alcohol Resistant Extended Release Multiparticulates Based on EUDRAGIT® NM 30 D

(M1130-08-53) Antioxidant Inclusion for the Preservation of Physical, Chemical, and Functional Properties of Polymeric Surfactants and Stabilizers during Terminal Sterilization (Gamma Irradiation)

(T1130-08-53) Miniaturized Screening Tool for Evaluating Solubility Enhancement Across Multiple Active Pharmaceutical Ingredients

(W1130-08-54) Feasibility Screening of Adsorption-Based Amorphous Solid Dispersions for Mefloquine HCl

(M1130-08-54) Investigating the Cause of Dissolution Failure of a Highly Soluble Pharmaceutical Salt Form of a Molecule

(T1130-08-54) Quinic Acid and ATP-Dual Ligand Nanoparticles for Systemic Cancer Chemoimmunotherapy

(W1130-09-56) Localized Immunomodulation Strategy for Enhanced Allogenic Cells Integration in Implantable Devices

(M1130-09-56) Nanoparticle Corona Composition Differs Due to Lifestyle Factors

(T1130-09-56) Nicotine Hydrogen Tartrate Containing Fast Dissolving Films: Formulation and In Vitro Evaluation

(M1130-09-57) Development of a Gefitinib-Loaded Niosomal Formulation for Pulmonary Delivery via Nebulization

(T1130-09-57) Enhanced Topical Delivery of Metronidazole: A Comparative Study of Single and Binary Solvent Systems

(W1130-09-57) Modelling Twin Screw Wet Granulation Process: Impact of L-HPC on Granules and Tablet Properties

(T1130-09-59) Controlling Nitrite Pathways in Drug Manufacturing to Prevent Nitrosamine Impurities: An Active Packaging-Based Approach

(M1130-09-59) Investigating the Release Profiles of Mesalamine Matrix Granules: EUDRAGIT® NM 40 D vs. EUDRAGIT® NE 40 D

(W1130-09-59) Low Molecular Weight Hydroxypropyl Cellulose as a Novel Protein Stabilizer for Parenteral Pharmaceuticals

(W1130-09-60) Development and Clinical Evaluation of a Dexmedetomidine Sublingual/Buccal Film Using MicroDep Technology: A Rapid-Absorbing High-Bioavailability Dosage Form

(M1130-09-60) Development of a Quantitative Method for Formulation Microenvironmental pH Assessment

(T1130-09-60) Tailoring Polyester Topologies for Efficient Oral Drug Delivery Systems

(W1130-09-61) Liver Targeting Lipid Nanoparticle for Gene Delivery by Click Reaction Modification

(M1130-09-61) Small-Angle X-Ray Scattering Analysis Reveals the Internal Structure of Lyotropic Liquid Crystalline Nanoparticles Encapsulating DNA

(T1130-09-61) Stability Evaluation of 4-Phenylbutyric Acid-Loaded Micro/Nano-Particulate Formulations for Topical Delivery Against Chemical Warfare Agent-Induced Skin Injury Using ICH Accelerated and Refrigerated Conditions

(W1230-06-34) Optimizing Skincare with a Multifunctional Approach: Development of a Facial Booster Microemulsion Using Box-Behnken Design

(W1230-06-35) Freeze-Dried Self-Microemulsifying Drug Delivery Systems and Lipidic Nanoparticles for Enhancing Oral Delivery of Cannabidiol

(T1230-06-35) Lectin Conjugated Liposome Nanocarriers for Targeted Bladder Cancer Therapy

(W1230-06-36) Adhesive Insights: Evaluating Mucoadhesion Across Various Polymers in Gel Formulations

(T1230-06-36) Scalable Theranostic Nanoemulsion for Sustained Non-opioid Analgesia: Modulating Macrophage Dynamics in Peripheral Nerve Injury

(M1230-06-37) Co-delivery of Paclitaxel with Adavosertib Encapsulated in Liposome for the Treatment of Ovarian Cancer

(W1230-06-37) Comparative Evaluation of Mucoadhesive Polymers Performance in Topical, Nasal, and Buccal Gel Formulations: Impact on Drug Product Physical Property, Behavior, and Patient Acceptability

(M1230-06-38) Improving Oral Bioavailability of Therapeutic Peptides with Lipid-Based Formulations and Ready-to-Use Enteric Capsules

(T1230-06-38) Kolliphor® P407-CPBA Functionalized PLGA Nanoparticles for Co-Delivery of Sorafenib and Venetoclax: A Synergistic Strategy Targeting Ferroptosis and Apoptosis in Breast Cancer

(M1230-06-39) A Breakthrough Predictive Model for Rapid and Accurate Solubility Parameter Prediction of Lipids for Lipid-Based Drug Delivery Systems

(W1230-06-39) Development of Sustained Release Isoniazid Formulation Using Twin Screw Melt Granulation

(T1230-06-39) Understanding the Interplay between Formulation and Process Variables to Fabricate Combination Printlets of Lamivudine and Tenofovir Disoproxil Fumarate for Pediatric Populations

(M1230-06-40) Leveraging the Digital Tool HyperStart C2C for the Development of Low Dose API Formulation and Comparative Analysis of Tablet Coatings

(T1230-06-40) Mechanism of Punch Sticking Induced by a Lubricant: Hydrogenated Vegetable Oil

(T1230-07-41) Development of 3D-Printed Chitosan/P-Coumaric Acid Scaffolds for Wound Healing: Antibacterial Properties and Drug Release Kinetics

(M1230-07-41) Mass Transport Analysis of the Particle Drifting Effect in a Biphasic Diffusion Apparatus

(W1230-07-41) Mesenchymal Stem Cell Derived Exosomes as Nanocarriers for Paclitaxel in Pancreatic Ductal Adenocarcinoma (PDAC) Treatment

(W1230-07-42) 3D Printed Ileum Targeted Tablet for the Treatment of IgA Nephropathy

(M1230-07-42) Myeloid Targeted Disulfide Lipid Nanoparticle with Enhanced Endosomal Escape Improves HIV-1 Excision

(M1230-07-43) Development and Evaluation of 2% (w/w) Apremilast Ointment for Psoriasis Management

(W1230-07-43) Development and Optimization of Curcumin-Loaded Polycaprolactone Nanoparticles Using Smart Technology

(M1230-07-44) Development of Directly Compressible Formulation of High Dose Calcium Citrate Tablets using Novel Clean Label Lubricant

(W1230-07-44) Process Optimization for Benzoic Acid Spherical Agglomeration: Bridging Liquid Solubility and Supersaturation of Primary Crystallization

(W1230-07-45) Comprehensive Design and Characterization of pH-Gradient-Loaded Donkey-Milk Exosomes for Oral Octreotide Delivery: A Bench-to-In Silico Roadmap

(T1230-07-45) Double RSM Design QbD Optimization of Emulsomal Gel

(T1230-07-46) Design and Optimization of Cannabidiol SEDDS Using Response Surface Methodology for Improved Drug Release and Stability

(M1230-07-46) Machine Learning Predicts Drug Release Profiles Based on Tablets’ Formulations

(M1230-07-47) Programmable Delayed-Release Container System (PDRCS) for Chronopharmaceutical Drug Delivery: Application to Addison’s Disease

(T1230-07-47) The Combination Use of Microcrystalline Cellulose and Lactose in Direct Compression

(W1230-08-49) Influence of Excipients on Interaction of Actives with the TR146 Model

(T1230-08-50) Development of a Novel Antimicrobial Gel for the Treatment of Endodontic Disinfection

(W1230-08-50) Preclinical Development of a Long-Acting Injectable Formulation of Rifapentine from High Throughput Screening through to a GLP-Toxicology Study

(M1230-08-50) Predicting Lung Dose and Asthma Control from Real-World Dry Powder Inhaler Use

(T1230-08-51) Establish a Mucosa-Mimicking In Vitro Permeation Model for Evaluating Mucoadhesive Formulations

(T1230-08-52) Lipidation of Kv1.3 Blocking Peptide HsTX1[R14A] Modulates Its Pharmacokinetics and Biodistribution to Target Tissues

(M1230-08-52) Potential of Ultra Fine Bubbles to Enhance Insulin Membrane Permeability

(W1230-08-52) Testing Formulation Effects of Itraconazole in a Miniaturized Precipitation Set-Up

(M1230-08-53) Impact of Porosity on Drug Release from PLGA Microspheres

(T1230-08-53) Investigation of the Internal Porosity and Drug Release Profile of Screw-Based 3D-Printed Bupropion Tablets

(W1230-08-53) Surelease^® Encapsulated Caffeine for Gummies

(M1230-08-54) Design of a Sprayable Powder Formulation Containing Choline-Maleic Acid Ionic Liquid in Porous Silica for Intranasal Delivery

(T1230-08-54) Enhancing Patient Experience in Topical Formulations: A Sensory-Based Strategy Using Rheology Modifiers and Emollients

(W1230-08-54) Overcoming Flow, Blend Uniformity and Direct Compression Tabletability Challenges in Micronized APIs Through Use of Multi-Functional Excipients

(W1230-09-56) Application of Precipitation Inhibitors in Lipid-Based Simvastatin Formulations to Prepare Simvastatin Amorphous Granules

(T1230-09-56) Challenges in the Development of Polycaprolactone Microparticles for H₂S Donor Encapsulation Using Coacervation

(M1230-09-56) Enhancing Lipid Nanoparticles Shelf Life with a Vitamin A Derivative

(T1230-09-57) Application of X-Ray CT Scan and Material Profiling to Evaluate Tableting Performance of Kollitab™ DC 87 L

(W1230-09-57) Innovative Formulation Strategies for orodispersible Loratadine Dosage Forms

(M1230-09-57) Optimization of Nifedipine Tablets with OROS Technology for Controlled Drug Release

(W1230-09-59) Application of Novel Partially Pregelatinized Cassava [tapioca] Starch as Substitute Filler-Diluent to Lactose in Personalized Substance-Abuse Therapy for Lactose Intolerant Population

(M1230-09-59) Investigation of Poly(meth)Acrylate-Based Technology and Enteric Polymers for Fast Duodenal Release

(T1230-09-59) Risk Mitigation of Nitrosamine Impurities in Drug Products Containing Secondary Amine APIs Through Excipient Nitrite Control

(W1230-09-60) A Preclinical Method to Quantify Complex Formulation Interactions with Serum Proteins and Target Tissues

(T1230-09-60) Development of Long-Acting Griseofulvin Formulations for Local Treatment of Ocular Neovascularization

(M1230-09-60) Predicting the Stability of Lyophilized Formulations Containing a Monoclonal Antibody and Sucrose/Trehalose Using Solid-State NMR Spectroscopy

(W1230-09-61) A Mutli-Mechanistic Three Polymer In Situ Gelling Ocular Drug Delivery Vehicle: Optimization under a DOE Strategy

(M1230-09-61) Careful Management of the Salt Disproportionation Risk of an In-House Developed Mono-Tartrate Salt (Compound 1)

(T1230-09-61) Physiologically Based Pharmacokinetic Simulations Using Transdermal Compartmental Absorption and Transit Model (TCAT) for RLS-1496 Dermal Preparations

(M1330-06-34) Approaches toward Nanostructured-Lipid Carriers (NLCs) for Disulfiram Delivery

(T1330-06-34) Design and Evaluation of Panobinostat-Loaded Albumin Nanocarriers for Pancreatic Tumor Treatment

(M1330-06-35) Brain-Targeted Delivery of Plasmid VGF through Trifunctionalized Liposomes for the Management of Alzheimer’s Disease

(T1330-06-35) Transdermal Administration of Rivastigmine Using Hydrogel-Forming Microneedles as a Potential Treatment for Alzheimer’s disease

(M1330-06-36) Exploiting Redox and Lipid Metabolic Vulnerabilities via Albumin-Encapsulated Oxaliplatin–Oleic Acid Prodrug for the Management of Triple-Negative Breast Cancer

(M1330-06-38) Optimization of Thermoresponsive SNEDDS Formulation Loaded with Dapagliflozin Using Box-Behnken Design Approach: Overcome Manufacturing Challenges

(T1330-06-38) Synergistic Effects of Fatty Acid Salt and Non-ionic Surfactant for Enhanced Solubilization and Amorphization of Sorafenib in Polymeric Matrix

(M1330-06-39) Brexanolone Inclusion Complexes with Hydroxypropyl- and Sulfobutylether-β-Cyclodextrins for Intravenous Injections: Formulation and Stability Studies

(T1330-06-39) Pea Starch as an Environmentally Sustainable Solution in Pharmaceutical Film Coating Applications Using the ReadiLYCOAT^® System

(T1330-07-41) From Pill to Patch: Transforming Plasmodium vivax Malaria Therapy with Hydrogel Microarray Patches

(M1330-07-41) Impact of Gastric Phase Simulation on the In Vitro Lipolysis of Lipid-Based Formulations Containing Ticagrelor or Fenofibrate

(M1330-07-42) Development of a Prototype Layer for a Multi-Layer Smart Bandage: Fabrication of Biopolymer-Based Hydrogels with Anti-Inflammatory and Antimicrobial Properties via 3D Bioprinting

(M1330-07-43) Biodegradable Nanoparticles for the Treatment of Triple-Negative Breast Cancer Fabricated by the Dispersion Polymerization Technique

(M1330-07-44) Patient In-Use Stability of FDA-Approved Delayed-Release Products of Divalproex

(M1330-07-45) Formulation of Rapidly Dissolving Amorphous Solid Dispersion of Posaconazole, an Extremely Water-Insoluble Basic Drug via Hot-Melt Extrusion by Applying Acid-Base Supersolubilization Principle

(T1330-07-45) Tailored Sodium Alginate-Based Hydrogel System for Submucosal Lifting: A Breakthrough in Endoscopic Mucosal Resection and Submucosal Dissection

(M1330-07-46) Development and In Vitro Evaluation of Modified Release Bupropion Hydrochloride Tablets for Enhanced Drug Delivery

(T1330-07-47) Fast-Dissolving Oral SMEDDS Films: A Novel Platform for Enhanced Delivery of Vitamin D3

(M1330-07-47) Tabletability Flip in Dry Granulated Systems

(T1330-08-48) Investigation of the Transdermal Delivery of Mangiferin Loaded Starch Nanoparticles

(M1330-08-50) Improving Intranasal Naloxone Delivery Using Excipients in a Tissue Model

(T1330-08-50) Thermo-Responsive F127-BUM as a Platform for Drug Delivery Innovation

(T1330-08-52) Developing a Minitablet Formulation for an NCE to Enable Dose and Administration Flexibility in Pediatric Clinical Trials

(M1330-08-53) Machine Learning and Automation Accelerate Formulation Development by Enabling Fast High-Throughput Screening for Long-Acting Injectable Drug Formulations

(T1330-08-53) Optimization of Tablet Coating Composition and Weight Gain for Moisture Protection Using Optimal Combined Design of Experiments (DOE)

(M1330-08-54) Critical Insights into High Drug Load Amorphous Formulations: Challenges and Advanced Techniques

(T1330-08-54) Mucoadhesive Buccal Tablets: A Patient-Centric Approach to Oral Mucosal Drug Delivery

(M1330-09-56) Neratinib Nanocrystals, Preparation, Characterization and In Vitro Evaluation Against Triple-Negative Breast Cancer

(T1330-09-56) Sodium Sulfide Nonahydrate (Na₂S·9H₂O), a Hydrogen Sulfide (H₂S) Donor and Its Solid-State Characterization

(M1330-09-57) Dissolution Enhancement Technique of Amorphous Solid Dispersions by External Addition of HPMCAS

(T1330-09-57) Efficient Manufacturing of Omeprazole Modified-Release Pellets Using Talc-Free Aqueous Coating System

(M1330-09-58) Berberine Hydrochloride Amorphous Solid Dispersion via Hot-Melt Extrusion for Taste Masking and Bioavailability Enhancement

(M1330-09-59) Development of Rifaximin Soluble Solid Dispersion (SSD): I. Solubility and Dissolution Advantage Over Commercially Available Xifaxan 550 mg Tablet

(T1330-09-59) Low-Substituted Hydroxypropyl Cellulose (L-HPC^®) Improves the Flowability and Compressibility of Acetaminophen via Twin-Screw Wet Granulation (TSWG): Comparison with Ac-Di-Sol^® and Kollidon^® CL

(M1330-09-60) Sustainability Considerations in Patient-Centric Formulation Selection

(T1330-09-60) Use of PBBM-PBPK to Predict Mesalamine Delayed-Release Oral Drug Products Performance in Both Healthy and Disease Physiologies

(T1330-09-61) Hollow Microneedle-Based Delivery of Voriconazole Ionic Liquid for Nail Fungal Infections

(M1330-09-61) Homogenization Process Conditions Affect the Chemical Stability of Polysorbate 80 and Globule Size Distribution of Castor Oil Emulsion

(M1430-06-35) Sustained Transdermal Delivery of Ropinirole Hydrochloride via Monolayer Dissolving Microneedle Array Patches

(T1430-06-36) Exploration of FDM 3D-Printed Multi-Compartment Drug Delivery Devices: Structural Modulation of Release Kinetics for Personalized Therapy

(M1430-06-36) Self-Micellizing Dry Powder Inhaler System for Cyclosporine A Using Sodium Stearate

(T1430-06-37) An Inhalable Spray Dried Powder of Linezolid and Antimicrobial Peptide for Tuberculosis Treatment

(T1430-06-38) A Computational Approach for Studying Drug Delivery Process Through Multilayered Drug Delivery Devices

(M1430-06-38) Effects of Sodium Alginate Properties on Mucoadhesion and Mucociliary Clearance

(M1430-06-39) Development of a Cannabidiol Dry Powder Inhaler Using Sodium Stearate: Enhancement of Aerosol Performance and Stability

(T1430-06-39) Effect of Formulation and Process Parameters on Fenofibrate Impregnation in Mesoporous Neusilin Particles

(T1430-06-40) Design and Evaluation of a Taste-Masked Sustained Release Effervescent Formulation of Caffeine

(M1430-06-40) Determination of Chemical Species Compound Concentrations (Free Form, Ion) during a Membrane Permeation Test Using Simulated Intestinal Fluid

(T1430-07-41) MMP-Sensitive Nanomedicine for Macrophage-Targeted Delivery of Coenzyme Q10

(M1430-07-42) Ripasudil Liposomes for the Treatment of a Polygenic Corneal Disease

(T1430-07-42) The Influence of Different HPMCAS Grades for Preparation of Enteric Capsules Investigated by MRI in Human Volunteers

(T1430-07-43) Sandwiched Nanofiber Sheets and Hybrid Gel for Localized and Prolonged Management of Cervical Cancer

(M1430-07-44) Exploring Powder Discharge-Based KinetiSol. a Modified KinetiSol® Process for Manufacturing Dry Powders for Inhalation: A Proof of Concept

(T1430-07-45) Development of Inhalable Tadalafil Formulations for the Treatment of Pulmonary Hypertension

(T1430-07-46) Advanced Characterization of Injectafer^®: Carboxymaltose Structure, Iron Core Structure, and Interaction of Carboxymaltose with Iron Core

(M1430-07-46) Formulation of a Hydrophilic Transdermal Patch for Combined Delivery of Sumatriptan and Metoclopramide in Migraine Therapy

(M1430-07-47) Impact of High Pressure on Structure and Thermal Properties of Amorphous Pharmaceuticals and Biopharmaceuticals

(T1430-07-47) Probing Dynamics of Amorphous Solid Dispersions Using Carboxylic Acid Dimer Formation

(T1430-08-50) Developments of Advanced Military Measure of Olfaction (AMMO) as an Indicator of Traumatic Brain Injury (TBI) Through Sense of Smell: Solving Excipient-Active Stability Interactions

(M1430-08-50) HPC vs HPMC – A Mechanistic Investigation on Bioadhesion via Swelling and Rheological Data

(M1430-08-52) Development of an Advanced Hydrogel-Based Drug Delivery System for Enhanced Neuroprotection in Traumatic Brain Injury

(T1430-08-52) Overcoming Formulation Challenges of an Unstable Amorphous Prodrug by API Sparing and Enteric Coating Approaches

(M1430-08-53) Development of Pediatric Immediate Release Mini-Tablet Formulation for a Novel FGFR Inhibitor Using Direct Compression and Functional Coating

(T1430-08-53) Development of Rifaximin Soluble Solid Dispersion (SSD). III XRPD Method Development to Evaluate % Crystallinity and Amorphousness

(T1430-08-54) Influence of Particle Morphology on Amorphous Solid Dispersion Drug Product Design

(M1430-08-54) Solubility Enhancement Using Anionic Poly(meth)Acrylate-Based Solid Dispersions

(M1430-09-56) Application of the Hot Melt Extrusion Risk Assessment Classification System (HCS) to a Poor Glass Forming, High Melting Point Drug

(T1430-09-56) Impact of Dosage Form on Drug Release from Danazol-ASD at LoC: A Comparative Study

(M1430-09-57) Engineering of Docetaxel Smart Crystalline Solid Dispersion for Prostate Cancer Therapy

(T1430-09-57) From Miscibility Modeling to Performance: Developing Stable ASD Granules of Nifedipine Using Poloxamer and Copovidone

(M1430-09-59) Control of Particle Size, Distribution and Modality of a Rifapentine Solid Drug Nanoparticle Formulation through Modified Formulation Approaches

(T1430-09-59) Glyco-Conjugated Mesoporous Silica Nanoparticles Enhance Meropenem Delivery against Multidrug-Resistant Bacteria and Biofilms

(M1430-09-60) Assessment of Antioxidant to Prevent Degradation in Moisture-Sensitive Tablets

(T1430-09-60) Solubility Enhancement of a Poorly Water-Soluble Drug Using Hypromellose Phthalate HP-50 by the Hot Melt Extrusion Process

(M1430-09-61) Preclinical Development of Long-Acting Injectable Formulations of Glecaprevir and Pibrentasvir for Curative Treatment of Hepatitis C in Low- and Middle-Income Countries

(T1430-09-61) Rational Development of Donepezil-Curcumin Intranasal Nanotherapies for Alzheimer’s Disease

(T1530-06-34) Designing Novel Modified Release Self-Emulsifying Drug Delivery Systems (n-SNEDDS) for Nasal Delivery with Enhanced Therapeutic Outcomes

(M1530-06-34) Fluorinated Polyethylene Glycol Decorated Liposomes for Mitochondria-Targeted Delivery of Heat Shock Protein Inhibitors

(M1530-06-36) Development of Polymeric Dual-Drug Nanoformulation: Enhancing Bioavailability and Preclinical Efficacy in Diabetic Nephropathy Treatment

(T1530-06-37) Engineering Oral Tablets with Precision: A Deep Dive into SLS 3D Printing, Drug Release, and Material Characterization

(T1530-06-38) Formulation of an Antimalarial Agent (ELQ-598) as a Sustained Release Injectable

(M1530-06-38) Massing Sensitivity Index (MSI): A Practical Tool to Investigate the Robustness for a High Shear Wet Granulation Formulation and Process

(T1530-06-39) Development and Evaluation of Stable 24-Hour Sustained-Release Tablet Formulations with Alcohol-Induced Dose Dumping Prevention

(M1530-06-39) Development of a Topical Meloxicam Formulation for Enhanced Transdermal Delivery

(T1530-06-40) Application of Colloidal Microcrystalline Cellulose in Reconstitutable Suspension

(M1530-07-41) Charge-Driven Nanocomplexation of Alexidine Reduces Its In Vivo Toxicity and Facilitates Its Development as a Broad-Spectrum Antifungal Agent

(T1530-07-41) Harnessing MSCs as a Tumor-Targeted Delivery Platform for Epigenetic and Chemotherapeutic Combination Therapy in Lung Cancer

(T1530-07-42) Leveraging Plant-Derived Extracellular Vesicles for Advanced Therapeutic Applications

(T1530-07-43) Effect of Gelling Agents on the Rheological Properties of Organogels Designed for Intramammary Administration

(M1530-07-44) Development of Clotrimazole Oral Films via Hot-Melt Extrusion for Improved Pediatric and Geriatric Drug Delivery

(T1530-07-44) Highlighting the Critical Role of Capsule Selection in Capsule Dry Powder Inhalation Aerosol Performances

(M1530-07-45) Exploring Freeze-Dried Polymeric Complexes with Different Fatty Acid Salts for Enhanced Olaparib Solubility and Permeation

(T1530-07-45) HPC-CA - A Novel Cellulose Derivate for Amorphous Solid Dispersion

(M1530-07-46) Spray Drying of Poorly Water-Soluble Drugs Without any Organic Solvent Using the Acid-Base Supersolubilization (ABS) Principle

(T1530-07-47) Control Over Microparticle Size Enables Precise Modulation of the Insufflator Spray Pattern and Olfactory Deposition in a 3D-Printed Nasal Model

(M1530-07-47) Predicting the Tabletability of Powder Mixtures Lubricated with Magnesium Stearate

(T1530-08-49) Preparation and Characterization of Cocrystals and Salts of an Indole-2-Carboxamide Anti-Mycobacterial Agent

(T1530-08-50) Chemical Profiling and Single-Solvent System Effects in Topical Cimetidine Formulations

(M1530-08-50) Comparison of Colloids from HPMCAS Grades Across Physiologically Relevant Media

(T1530-08-51) Synthesis and Characterization of Biodegradable Polymer Backbone for the Development of Dual-Drug Polymer Conjugate for Pancreatic Cancer Treatment

(T1530-08-52) Development of a Gastro-Retentive Bimodal Release Bilayer Tablet to Enable Once-Daily Dosing, Fast Onset and Blunted C_max for an NCE with Short Half-Life

(M1530-08-52) Enhancing Amorphous Solid Dispersion Polymer Screening: A High-Throughput Approach with Fully Automated Sampling

(T1530-08-53) ASD Formulation to Unit Dosage Form: Integrated Drug Product Development with Dispersome

(M1530-08-53) Facilitating Robust Manufacturing of Low-Dose Oral Solid Drug Products using Directly Compressible Mannitol

(M1530-08-54) Compatibility Assessment of Ready-to-Fill Delayed Release Capsules with Self-Nanoemulsifying Drug Delivery Systems (SNEDDS)

(T1530-08-54) Modulating Precipitation of Small Molecule Drugs upon Intraperitoneal Injection Using Cyclodextrin Containing Formulations

(T1530-09-56) Antioxidant Screening for the Inhibition of N-nitroso Propranolol Formation in Solution and Solid-State

(M1530-09-56) Rational Design of Topical Semi-Solids: An All-Virtual, Inverse Design Process

(M1530-09-57) Cocrystallization: A Strategy to Tune Surface Composition and Improve Wettability of Hydrophobic Drugs

(T1530-09-57) Development of Long-Acting Bupivacaine-Loaded Multivesicular Liposomes Using Prilling Technique

(T1530-09-59) Effects of Permeation Enhancers on the Epithelial Transport and Bioavailability of the Proteolysis Targeting Chimera (PROTAC) ARV-471 in Rats

(M1530-09-59) Solid-Phase Strategy for High-Yield Diversification and Functional Evaluation of Ionizable Triazine Lipids for mRNA Delivery

(M1530-09-60) Algorithm-Based Excipient Selection for Solid Dispersion Development

(T1530-09-60) Lipid-Based Formulations: How to Predict Rat In Vivo PK Profile with In Vitro + In Silico Approach

(M1530-09-61) Development and Optimization of Liquisolid Compacts of Febuxostat Using Conventional Processing and Twin-Screw Granulation: A Comparative Study for Solubility and Dissolution Enhancement

(T1530-09-61) Hansen Solubility Parameter-Based Modeling to Improve Solubility Profiling of Challenging APIs and Accelerate Formulation Development

(T0930-02-09) A Streamlined Workflow for Visible Particulate Identification and Root Cause Mitigation in Biologic Drug Products

(W0930-02-09) Recombinant Adeno-Associated Virus (rAAV) Production in Spodoptera Frugiperda (Sf9) Cells: Viral Cathepsin Mediated Capsid Cleavage and Mitigation Strategies

(T0930-02-10) Improved Identification of Host Cell Proteins in Monoclonal Antibodies by Combining Filter-Aided Sample Preparation and Native Digestion

(M0930-02-11) Investigation of Abnormal Trend for Reduced CE-SDS and Continuous Method Performance Monitoring in Quality Control Testing of Monoclonal Antibody

(W1030-02-09) Characterization of Cell-Penetrating Peptide-Phosphorodiamidate Morpholino Oligonucleotides Using an On-Line Nanoflow Desalting Method

(M1030-02-09) Connecting ADA-SCID Manufacturing to Outcomes: A Case Study in Predictive Analytics for Product Understanding

(T1030-02-09) Understanding the Compatibility of CSTDs with Container Closure Systems in Accordance with USP < 382 > to Meet Functionality Requirements

(T1030-02-10) Enhancing Analytical Sensitivity in Upstream Bioreactions Using Time-Gated Raman Spectroscopy

(T1030-02-11) First-in-Class 3D Bioprinting Technology for the Scalable Production of Complex Vaccines Targeting Influenza and Emerging Pathogens

(M1030-02-13) Protein-Surfactant Interactions at Solid-Liquid Interfaces of Diverse Primary Packaging Materials for Biopharmaceuticals

(W1030-02-13) Spray-Drying of Peptides: From Small to Clinical Scale

(M1030-02-14) Case Study: Viral Inactivation in Bioprocessing Using Hydroxypropyl Beta-Cyclodextrins, a Compendial Excipient

(M1130-02-08) Comprehensive Characterization of Adeno-Associated Virus Capsid Proteins via Peptide Mapping and Post-Translational Modification Analysis

(T1130-02-08) End-To-End Process for Improved Purity, Combined with Innovative Analytics of LNP-Based Therapeutics

(W1130-02-09) Evaluating Analytical Methods for Moisture Determination in Sulfobutylether β-Cyclodextrin and Characterization of Sorption Behavior by DVS

(T1130-02-09) Optical Coherence Tomography as a Real-Time Tool to Monitor Sublimation Properties of Lyophilized Cakes

(M1230-02-09) Separation and Structural Analysis of Heavily Modified Therapeutic RNAs Using Hydrophilic Interaction Liquid Chromatography Coupled to Advanced Ion Activation Techniques for Tandem Mass Spectrometry

(M1230-02-10) Probing Product Quality of Lyophilized Formulations Via Solid-State Nuclear Magnetic Resonance Spectroscopy

(T1230-02-14) Tubing and Preservative Loss during Static Holds: Analysis and Recommendations for Manufacture of Preservative Containing Formulations

(T1330-02-09) Evaluating Static and Dynamic Interactions between Preservative and Tubing during Filling of Parenteral Liquid Formulations

(M1330-02-09) GLP-1 Analog: Accelerating Method Development and Manufacturing with LC-UV/MS

(M1330-02-10) Direct and Automated Multi-Attribute Testing of Biologic Formulation with Benchtop NMR

(M1330-02-12) Annealing as a Tool to Tailor Powder Morphology in Spray Freeze Drying

(T1330-02-14) An Advanced LC-QTOF-MS Method for Accurate Characterisation of a Next Generation Vaccine

(M1330-02-14) Continuous Manufacturing of Biological Drug Products for Pulmonary Drug Delivery

(M1430-02-10) Defining a Scale-Down Agitation Model for Early-Stage High Concentration Biologics Formulation Development

(M1530-02-09) Tomographic Characterization of Alginate Foam Scaffolds for 3D Cell Growth

(T1530-02-09) Validating the Measurement of Loss of Cell Surface CD6 on CD4 T-Cell Based Potency Assay Using Flow Cytometry

(M1530-02-10) Highly Concentrated mAb SubQ Formulations Using Nanoformed Particles: Trastuzumab Case Study

(T0930-02-08) API – Polymer Interactions with Dissolution Media: A Key Consideration in Method Development for Amorphous Solid Dispersions

(M0930-02-08) Impact of Excipient Properties on Coning during Dissolution for Ibuprofen Formulations

(W0930-02-08) Optimization of UV Detector Parameters of Compendial Methods

(M0930-02-09) Revealing the Stable δ²H, δ¹³C, and δ¹⁸O Isotopic Patterns of Ibuprofen Drug Products and Commonly used Pharmaceutical Excipients

(W0930-02-10) Enabling Advanced Manufacturing Technologies and Quality by Control (QbC) with the Implementation of Advanced Process Control

(T0930-02-11) Enhancing Environmental Sustainability in the Korean Pharmacopoeia: Replacement of Carbon Tetrachloride in the Monograph for Epinephrine Injection

(W0930-02-11) Impact of Direct Vs Indirect Simulation on Material Strength and Deformation Parameters

(W0930-02-12) A High Throughput In Vitro Screening Method for Cocrystal Food Effect Evaluation

(M0930-02-12) CFD-DEM Modeling of Floating Particle Mixing in Pharmaceutical Manufacturing

(T0930-02-12) Real-Time Monitoring of Selective Laser Sintering 3D Printing Process For Lamivudine Content Quantification in the Printlets

(W0930-02-13) Continuous Manufacturing of Injectable Nanoemulsions: Methods and Characterization

(T0930-02-13) Influence of Temperature, Vacuum, and Humidity on Drying Kinetics of Citric Acid Monohydrate

(M0930-02-14) Development of Powdered SERS Tags for Direct Compression: Toward On-Dose Authentication for Anti-Counterfeiting and Medication Management

(W0930-02-14) HPLC Method Development for Assay of Common Topical Formulation Preservatives

(T0930-02-14) Quantitative Structural and Compositional Elucidation of Real‑World Pharmaceutical Tablet Using Large Field‑of‑View, Correlative Microscopy‑Tomography Techniques and AI‑Enabled Image Analysis

(M1030-02-08) Evaluation of Tableting Characteristics of Copovidone-Based ASDs Using CTC and Heckle Analysis

(W1030-02-08) Raman Spectroscopy as a PAT Tool for Hot Melt Extrusion

(T1030-02-08) Rethinking In Vitro Testing: Using Biorelevant Media for Dispersion/Dissolution Testing for Lipid-Based Drug Delivery

(W1030-02-10) Detection of Xanthines and Several Beta-Lactam Antibiotics Using Surface Modified Lipid/Polymer Membranes

(M1030-02-10) Drugs in Space: Evaluating the Effects of Drug-Product Package Changes in Drug Stability

(W1030-02-11) Ethanol Vapour-Induced Morphological Influences on the Water Barrier Performance of PLA Packaging: A Multi-Component Study

(M1030-02-11) Nitrite Detection at Trace Levels: Insights from a Lactose Case Study on Ion Chromatography and Sonication Effects

(T1030-02-12) Consistent Dry-Coating Process for Preparing Functional Particles with Novel Coating Using Two-Step Melt Granulation

(W1030-02-12) Crystal Defects Cause Nitrosamine Formation in Ranitidine under Accelerate Storage Condition

(M1030-02-12) Decoding Choice of Surrogate Compounds for TSMG Empirical Modelling of Gabapentin - A Case Study

(T1030-02-13) Investigating Granule Temperature Dynamics and Its Impact on Granule Properties during Long TSMG Runs

(T1030-02-14) Quality Demonstration of Personalized Mini Tablet Manufacture Using Integrated Single-Dose Manufacturing System

(W1130-02-08) Room-Temperature Aerosol Dehydration Enables Production of Stable Bevacizumab Powder from FDA-Approved Avastin®

(M1130-02-09) Powder Rheology for Batch Comparison During Manufacturing

(W1130-02-10) Defining a Robust, Discovery-Scale Process to Manufacture PLGA Microsphere Prototypes

(T1130-02-10) The Use of Raman Mapping and Hot-Stage Microscopy to Detect Micro-Domains of Crystallinity in Amorphous Solid Dispersions of Nilotinib

(M1130-02-10) Understanding How UHPLC System Characteristics Effect “Going Green” with Regulated Methods

(W1130-02-11) Adapting USP Monographs to the Capillary Scale using USP 621

(T1130-02-11) Impact of Material Spring Behavior on the Sticking Propensity During Tablet Manufacturing: Part 1- Single Component Pharmaceutical Systems

(M1130-02-12) Establishing the Mechanism of Immediate Release Film Coating Dissolution Using Terahertz Measurements

(W1130-02-12) Sustainable Separation: Supercritical Fluid Chromatography as a Modern Replacement for Normal Phase Chromatography

(T1130-02-12) Why Rheology Matters: Insights into Granulation Behavior in Twin-Screw Melt Granulation

(T1130-02-13) Microscope-Enabled Disc Dissolution System: Concordance between Drug and Polymer Dissolution from an Amorphous Solid Dispersion Disc and Visual Disc Degradation

(W1130-02-13) Multi-Compartment In Vitro Dissolution Testing to Study the Potential Impact of API Changes on Drug-in-Capsule Absorption for Mobocertinib, a Weak Base with Complex pH-Dependent Solubility

(W1130-02-14) Contactless, Real-Time Thermal Profiling and Control of Exothermic and Endothermic Reactions

(M1130-02-14) Enabling Inline Concentration Control: Refractometry as a PAT Tool in Continuous Manufacturing of Lipid-Based Therapeutics

(T1130-02-14) Low Viscosity Hypromellose for Capsule Banding and Tablet Coating Applications via Ethanol (Isopropanol)/Water Solvent Media

(M1230-02-08) Discrete Element Method (DEM) Study of a Batch Blending Process

(T1230-02-08) UPLC Investigation for Understanding Excipient Interactions to Enhance Stability in a Transdermal Apixaban Delivery System

(T1230-02-09) Establishing Linear Viscoelastic Region and Gelation Dynamics in Anhydrous Intra Nasal Gel: Rheological Insights toward Optimized Patient-Centric Formulations

(T1230-02-10) Unraveling the Bridging Region of Lenacapavir Atropisomers by 2D-LC

(T1230-02-11) Engineering and Formulation Space Optimization of pH-Sensitive Granules for Delayed Drug Release by Twin Screw Melt Granulation

(M1230-02-11) Synergistic Integration of Twin-Screw Hot-Melt Granulation and Selective Laser Melting for High-Dose Extended-Release 3D-Printed Tablets

(M1230-02-12) Improving Stability and Sustainability of an Auto-Oxidative Excipient, Polyethylene Oxide, with Foil-Lined Packaging

(T1230-02-12) Producing ASDs with Pressure Nozzles Using Laboratory Scale Spray Dryers

(M1230-02-13) Mechanistic Understanding of Sodium Metabisulfite-Induced Drug Degradation: An Interplay of In Silico and Experimental Studies

(T1230-02-13) Spray Dry Granulation in Fluid Bed Technology and Scale Up

(M1230-02-14) Optimization of Roller Compaction Process for Highly Unstable Drug Substance Susceptible to Degradation in Presence of Moisture, Oxygen and Magnesium Stearate

(M1330-02-08) Chromatographic Method for Determination of 6-mercaptopurine in Skin Permeation Assays

(T1330-02-08) Super-Fast Fabrication of Drug Nanocrystals Using Dual Asymmetric Centrifugation: An Efficient Approach for High-Throughput Formulation Screening

(T1330-02-10) Development of a SMEDDS-Based Tablet for Sustained Release and Improved Solubility of Apixaban

(M1330-02-11) Aseptic Spray Drying and Homogenization for the Manufacture of a Sterile Long-Acting Injectable (LAI) Formulation

(T1330-02-11) Impact of In-Die Compression Behavior on the Sticking Propensity During Tablet Manufacturing: Binary Component Pharmaceutical Systems

(T1330-02-13) Role of Surface Morphological Characteristics of Substrate in Adhesion Performance of Topical and Transdermal Delivery Systems (TDS)

(M1330-02-13) Scalable Agile 3D Material Inkjet Printing and Analysis of Oral Pharmaceuticals – A Case Study for Digitally Prescribed Dose and In-Line Dose Verification

(T1430-02-08) LC-MS Workflow for Rapid and Precise Impurity Profiling of Oligonucleotides and GLP-1a

(M1430-02-08) Quantitating Swelling Pressure Generated by the Push Layer of an Osmotic Pump Tablet

(M1430-02-09) Advancing Lean Chemometrics: Minimizing Material Expenditure with Iterative Optimization Technology

(T1430-02-09) Cracking the Chromatographic Code: Innovative Solutions to Address Keto-Enol Tautomerism in LC Method Development

(T1430-02-10) Development of a Modified Arrhenius Equation to Predict the Kinetics of N-nitrosation of Active Drug in Solid Dosage Form

(M1430-02-11) Fast and Efficient Development of a DC Formulation of Ondansetron Tablets Guided by a Digital Tool

(T1430-02-11) Monitoring of NO_X Concentration on Fluidized Bed Dryer and Evaluation of Its Reduction Method

(M1430-02-12) Development of Combination Printlets of Sulfadiazine and Pyrimethamine Using Selective Laser Sintering 3D Printing for Pediatrics Applications

(T1430-02-12) Highly Controlled Drug Nanoparticles Generation by Vapor Jet De-sublimation

(M1430-02-13) Diethylene Glycol and Ethylene Glycol Challenges: Compendial Approach and Emerging Standards

(T1430-02-13) Evaluation of Compaction Properties of Several Hydrophilic Polymers and Tableting Components in the Development of a Prototype Directly Compressible Gastroretentive Extended-Release Tablet

(M1430-02-14) Application of Microstructure Quality by Design Approach in Optimizing Granulation and Tablet Physico-Mechanical Attributes

(T1430-02-14) Risk-Based Computer System Validation in Pharmaceutical Quality Systems: Practical Outcomes from an Analytical Laboratory Implementation

(M1530-02-08) Compression Process Optimization Using a 2^3 Full Factorial Design of Experiments

(T1530-02-10) Spray Drying of Low Organic Solubility Pharmaceutical Compounds, a Vemurafenib Case Study

(T1530-02-11) Analysis of Lubrication Process Impact on Formulation Blend and Tableting Properties with Numerical Models and Statistical Analysis

(M1530-02-11) Die Modeling for Extruded Implants

(T1530-02-12) Development of Spray Freeze Drying as a Novel Strategy to Enhance the Oral Delivery of Proteins/Peptides

(M1530-02-12) Powder-Discharge KinetiSol® Process Produces Nano- and Micron-Sized Particle Aggregates for Drug Delivery

(T1530-02-13) De-Risking Tablet Formulation Development Using Compaction Simulation

(M1530-02-14) Functional Evaluation of Disintegrants Mixed into Pharmaceutical Excipients Based on Dynamic Viscoelastic Measurements

(T1530-02-14) Scaling-Up from the Bench: Model Based Approaches to Dry Granulation

(W0930-05-27) Decellularization of Porcine Bladder as a Biocompatible Platform for Evaluating In Vitro Drug Efficacy

(M0930-05-27) In Vivo Preclinical Pharmacokinetics of Nortriptyline and Its Application to Develop a Physiologically Based Pharmacokinetic Model

(T0930-05-27) Toward Disease-Specific Digital Twins of Ex Vivo Human Lungs for Restrictive and Obstructive Lung Diseases Using Machine Learning

(T0930-05-28) Cellular Mechanisms Underlying Species-Related Differences in Effective Delivery of LNP-mRNA

(W0930-05-28) Exploring the Effects of Nano-Enabled Oral Insulin and Anti-Inflammatory Agent in Mitigating Diabetic Ocular Complications in Type 2 Diabetic Rat Model

(M0930-05-28) In Vitro ADME, Mouse Pharmacokinetics, and Bioanalysis of LD14b: A Novel Aβ 17β-HSD10 Modulator for the Treatment of Alzheimer’s disease

(W0930-05-29) Pharmacokinetic Differences of Paclitaxel and Cyclopamine in Healthy and HCC Mice when Co-administered via Polymeric Micelle and Cremophor EL

(M0930-05-29) Sustained Drug Exposure Drives Efficacy: PK/PD Analysis of Corallopyronin A against Wolbachia Using Physiologically Based Biopharmaceutic Modeling

(T0930-05-29) Transdermal Delivery of Enfuvirtide Using Dissolving Microneedles Integrated with Insertion and Removal Indicator

(W0930-05-30) Machine-Learning-Based Assessment of Breast Tumor Malignancy Through Nuclear Morphological Features

(M0930-05-30) PBPK-Based Prediction of Obesity-Mediated Changes in Small Molecule Pharmacokinetics

(M0930-05-31) Model-Informed Precision Dosing of Riluzole in Acute Spinal Cord Injury Using Pharmacokinetic, Pharmacodynamic, and Clinical Outcome Modeling

(T0930-05-31) Non-invasive In Vivo Imaging of β-Cell Function in the Rodent Pancreas Using a Zinc-Responsive Contrast Agent

(W0930-05-31) User-Friendly Web Applications for Pharmacokinetic Simulations and Predictions

(T0930-05-32) A Mechanistic Framework for PBPK Modelling of the Impact of Osmotically Active Species, including Excipients, on Oral Drug Absorption: The Underlying Mechanistic Model

(M0930-05-32) Nonparametric Superposition and Simulation to Predict Recommended Dosing of Ecopipam for Patients with Various Degrees of Chronic Hepatic Insufficiency

(M0930-05-33) A Gut-Hepatobiliary Organ Perfusion Model: Demonstrator Study Showing the Absorption, Metabolism, and Excretion of Midazolam

(T0930-05-33) Direct Diffusion–Driven Salivary Gland Accumulation of Buprenorphine Following Sublingual Administration Promotes Dental Caries

(M1030-05-27) Charge-Tunable Synergistic Nanotherapeutics for Lung Cancer: Reactivating Tumor Suppressor p53 While Inhibiting DNA Synthesis

(T1030-05-27) Tamoxifen and Metabolite Effects on Cellular Metabolism in Pancreatic Cancer Cell Lines

(T1030-05-28) Enhanced Intravitreal Pharmacokinetics in the Simcyp™ Ocular Model

(M1030-05-28) Genetically Engineered Multifunctional Immune-Modulating Exosomes (GEMINI-Exos) for Colorectal Cancer Treatment

(M1030-05-29) Evaluation of Pharmacokinetic Characteristics and the Food Effect of Radotinib in Healthy Volunteers

(T1030-05-29) Population Pharmacokinetic Modeling of Rezpegaldesleukin after Subcutaneous Dosing to Account for Variability Across Multiple Patient Populations with Autoimmune Diseases

(M1030-05-30) Modelling and Simulation of Fentanyl Matrix Patches and Risk Assessment from Manufacturing Errors

(T1030-05-30) Toward a Physiologically Based Pharmacokinetic Model for Topical Ophthalmic Suspension

(T1030-05-31) Harnessing a Cutting-Edge Time-Lapse Flow Cytometry Platform for Enhanced Immunogenicity Assessment

(M1030-05-31) Maintaining Liver Viability, Functionality and Metabolic Capacity During Multi-Day Machine Perfusion

(T1030-05-32) Gender Differences in the Pharmacokinetics, Tissue Distribution and Metabolism of a Potent Pulmonary Arterial Hypertension Therapeutic Drug ZEX in Mice

(M1030-05-32) Synthesis, Characterization, and Stability of Iron-Chlorophyll Derivatives (ICDs)

(M1030-05-33) AI-Enhanced Regulatory Inspection Platform: A Multi-Modal System for Automated Report Generation and Compliance Assessment

(M1130-05-27) Brain Mitochondrial Metabolic Alterations In VCD-Induced Menopause Model

(T1130-05-27) Characterizing Population Variability in Vaccine-induced Immunity: A Machine Learning Integrated Mechanistic Modeling Approach

(M1130-05-28) Clay Attenuates Diarrhea Induced by Fat in a Mouse Model

(T1130-05-28) Toward IVIVC (In Vitro-In Vivo Correlation) for Glycosidic Compounds: Optimization Study of β-Glucosidase Addition Levels in Membrane Permeation Tests

(T1130-05-29) Integrating Targeted Proteomics and Ocular Pharmacokinetics to Support PBPK Modeling of Carboxylesterase-Mediated Drug Metabolism in the Eye: A Case Study with Latanoprost Ophthalmic Solution

(M1130-05-29) Optimization and Application of an In Vitro Direct Contact Neurovascular Unit Model to Assess Neurotoxicity

(M1130-05-31) A Mathematical Model Describing the Activity of Proton Gradient-Driven MATE Transport

(T1130-05-31) Combining Biorelevant Dissolution, Machine Learning, and PBBM to Explore Drug Exposure Variability due to Gastric Contractions and pH: A Case Study of Dabigatran Etexilate Capsules

(T1130-05-32) Acoramidis Improved Clinical Outcomes, Function, Quality of Life and NT-proBNP in Patients with Transthyretin Amyloid Cardiomyopathy Regardless of Atrial Fibrillation Status at Baseline

(M1130-05-32) Fatigue Forecasting in Long COVID Using Wearable Heart Rate Variability Monitoring

(T1130-05-33) Drug Tolerance Enhancement in a Ligand Binding Neutralizing Antibody (NAb) Assay using Affinity Extraction

(M1130-05-33) Physicochemical and Biopharmaceutical Characterization of Locally Bioavailable COX-2 Inhibitor for Familial Adenomatous Polyposis

(M1230-05-27) CCR5 Receptor Targeted Lipid Nanoparticles for HIV-1 Proviral DNA Excision

(T1230-05-27) Human Pharmacokinetics Prediction for Trastuzumab Using Scaling and Two-Compartment Modeling with B-hFcRn Mice PK Data

(M1230-05-28) Acoramidis Reduces All-Cause Mortality and First Cardiovascular Hospitalization in Patients with Variant Transthyretin Amyloid Cardiomyopathy: Results from the ATTRibute-CM Study

(T1230-05-28) Characterization of an Inhouse Developed Human Hepatocyte Co-culture Model for Evaluating Induction of Cytochrome P₄₅₀ CYP2C Enzyme Family

(M1230-05-29) Formulation Development of Extemporaneously Prepared Mucoadhesive In Situ Forming Gels for Oral Mucositis Pain Control

(T1230-05-30) Sensory Panel Tests for Topical Semi-Solid Creams: Correlation between Sensorial Perceptions and Product Critical Quality Attributes

(T1230-05-31) Hepatocyte Uptake Assay to Improve IVIVC Disconnects of Lipophilic Acids

(M1230-05-31) Physiologically Based Biopharmaceutics Modeling of Formulation Bioequivalence for Mobocertinib, a Weak Base, Using pH-Dependent Dissolution Data

(M1230-05-32) 2024-2025 FDA 505(b)(2) Drug Approvals: Insights into Pharmaceutical Products and Their Reformulation Challenges and Therapeutic Indications Trend

(T1230-05-32) Acoramidis Lowers NT-proBNP in a Larger Proportion of ATTRibute-CM Study Participants with Transthyretin Amyloid Cardiomyopathy Compared with Placebo, Independent of Atrial Fibrillation Status